
(
  (S
    (NP
      (NP (JJ Stage-specific) (NNS changes))
      (PP (IN in)
        (NP (JJ fetal) (NN thymocyte) (NN proliferation)))
      (PP (IN during)
        (NP (DT the) (JJ CD4-8-) (TO to) (NN CD4+8+) (NN transition)))
      (PP (IN in)
        (NP
          (NP
            (NP (JJ wild) (NN type))
            (, ,)
            (NP
              (ADJP (JJ Rag1-/-)))
            (, ,)
            (CC and)
            (NP (NN Hoxa3))
            (, ,)
            (NP (NN Pax1)))
          (JJ mutant) (NNS mice))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (NP
          (NP (DT The) (NN function))
          (PP (IN of)
            (NP (DT the) (JJ thymic) (NN microenvironment))))
        (VP (VBZ is)
          (S
            (VP (TO to)
              (VP (VB promote)
                (NP (NN thymocyte) (NN maturation))
                (, ,)
                (PP (IN in)
                  (NP (NN part)))
                (PP (IN via)
                  (NP
                    (NP (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (NN thymocyte) (NN proliferation))
                        (CC and)
                        (NP (NN cell) (NN death)))))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NNS Defects))
        (PP
          (PP (IN in)
            (NP
              (NP (JJ fetal) (JJ thymic) (NN epithelial) (NN cell) (-LRB- -LRB-) (NN TEC) (-RRB- -RRB-) (NN development))
              (CC and)
              (NP (NN function))))
          (, ,)
          (CC and)
          (RB therefore)
          (PP (IN in)
            (NP
              (NP (DT the) (NN formation))
              (PP (IN of)
                (NP (DT a) (JJ functional) (NN microenvironment)))))
          (, ,)))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN caused)
            (ADVP (CC either)
              (ADVP (RB directly)
                (PP (IN by)
                  (NP (NN TEC) (NN differentiation) (NNS defects))))
              (CC or)
              (ADVP (RB indirectly)))
            (PP (IN by)
              (NP (JJ defective) (NN thymocyte) (NN maturation)))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT this) (NN paper)))
    (NP (PRP we))
    (VP (VBD studied)
      (NP (JJ fetal) (NN thymocyte) (NN proliferation))
      (PP (IN during)
        (NP
          (NP (DT the) (JJ early) (NN transition))
          (PP (IN from)
            (NP
              (NP (DT the) (JJ CD3-4-8-))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (JJ triple) (JJ negative))
                  (, ,)
                  (NP (NN TN)))
                (-RRB- -RRB-))))
          (PP (TO to)
            (NP
              (ADJP
                (ADJP (JJ CD4+8+))
                (PRN (-LRB- -LRB-)
                  (FRAG
                    (NP (JJ double) (JJ positive))
                    (, ,)
                    (NP (NN DP)))
                  (-RRB- -RRB-)))
              (NNS stages))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD compared)
        (NP
          (NP (JJ wild) (NN type))
          (NNS mice))
        (PP
          (PP (IN with)
            (NP (JJ Rag1-/-) (NNS mice)))
          (CC and)
          (PP (IN with)
            (NP
              (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NNS mice))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP have)
                    (NP (NNS blocks))
                    (PP (IN at)
                      (NP
                        (NP (JJ different) (NNS stages))
                        (PP (IN of)
                          (NP (NN thymocyte) (NN development)))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (NP (JJ Wild) (NN type)
          (ADJP
            (ADJP (JJ fetal))
            (CC and)
            (ADJP (JJ adult)))
          (NN thymus))
        (VP (VBD showed)
          (NP
            (NP (JJ stage-specific) (NNS differences))
            (PP (IN in)
              (NP
                (NP (DT the) (NN proliferation) (NNS profiles))
                (PP (IN of)
                  (NP (VBG developing) (NNS thymocytes))))))
          (, ,)
          (PP (IN with)
            (NP
              (NP (JJ fetal) (NNS stages))
              (VP (VBG showing)
                (NP
                  (NP
                    (ADJP (RB generally) (JJR higher))
                    (NNS levels))
                  (PP (IN of)
                    (NP (NN proliferation)))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN proliferation) (NN profile))
        (PP (IN of)
          (NP
            (NP (JJ fetal) (NNS thymocytes))
            (PP (IN from)
              (NP (JJ Rag1-/-) (NNS mutants))))))
      (ADVP (RB also))
      (VP (VBD had)
        (NP
          (NP (JJ stage-specific) (NNS increases))
          (PP (IN in)
            (NP (NN proliferation))))
        (PP (VBN compared)
          (PP (TO to)
            (NP (JJ wild) (NN type) (JJ fetal) (NNS thymocytes))))
        (, ,)
        (PP (IN in) (NN contrast) (TO to)
          (NP
            (NP (DT the) (JJR lower) (NN proliferation))
            (VP
              (ADVP (RB previously))
              (VBN reported)
              (PP (IN for)
                (NP
                  (NP (NNS thymocytes))
                  (PP (IN from)
                    (NP (JJ adult) (JJ Rag1-/-) (NNS mutants))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice))
              (VP (VBP have)
                (NP (JJ abnormal) (JJ fetal) (NN TEC) (NN development))
                (, ,)
                (S
                  (VP (VBG resulting)
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (VBN increased) (NN apoptosis))
                          (PP (IN at)
                            (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))))
                        (CC and)
                        (NP (VBN decreased) (NN DP) (NN cell) (NNS numbers))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Fetal) (NNS thymocytes))
        (PP (IN from)
          (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))))
      (VP (VBD had)
        (NP (VBN increased) (NN proliferation))
        (, ,)
        (CC but)
        (NP (JJR fewer) (VBG proliferating) (NNS cells))
        (, ,)
        (PP (IN at)
          (NP (DT the) (NN DP) (NN stage)))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD observed)
        (NP
          (NP (DT a) (NN decrease))
          (PP (IN in)
            (NP
              (NP (DT the) (NN level))
              (PP (IN of)
                (NP
                  (NP (DT the) (NNS cytokines)
                    (NP
                      (NP (NN IL-7))
                      (CC and)
                      (NP (NN SCF))))
                  (VP (VBN produced)
                    (PP (IN by)
                      (NP (NN Hoxa3+/-Pax1-/-TECs.) (NN Conclusion)))))))))))
    (: :)
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBP indicate)
        (NP
          (NP
            (ADJP
              (ADJP (JJ complex))
              (CC and)
              (ADJP (JJ stage-specific)))
            (NNS effects))
          (PP (IN of)
            (NP (JJ abnormal) (NN TEC) (NN development)))
          (PP (IN on)
            (NP (NN thymocyte) (NN proliferation))))))
    (. .)))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP (NN Thymocyte) (NN development))
      (VP (VBZ occurs)
        (PP (IN within)
          (NP
            (NP
              (NP (DT a) (JJ complex) (NN network))
              (PP (IN of)
                (NP (NNS cells))))
            (, ,)
            (NP (JJ extracellular) (NN matrix))
            (, ,)
            (CC and)
            (NP
              (NP (JJ secreted) (NNS factors))
              (VP (VBN referred)
                (PP (TO to))
                (PP (IN as)
                  (NP
                    (NP (DT the) (JJ thymic) (NN microenvironment))
                    (NN -LSB-1)))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Current) (NN evidence))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (DT this) (NN microenvironment))
            (VP (VBZ is)
              (VP (VBN created)
                (PP (IN during)
                  (NP (JJ fetal) (NN thymus) (NN organogenesis)))
                (PP (IN through)
                  (NP
                    (NP (JJ stage-dependent) (NNS interactions))
                    (PP (IN between)
                      (NP
                        (NP
                          (NP (JJ differentiating) (JJ thymic) (JJ epithelial) (NNS cells))
                          (PRN (-LRB- -LRB-)
                            (NP (NNS TECs))
                            (-RRB- -RRB-)))
                        (CC and)
                        (NP (VBG developing) (NNS thymocytes) (CD -LSB-2-6) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (NNS blocks))
        (PP (IN at)
          (NP
            (NP (JJ different) (NNS stages))
            (PP (IN of)
              (NP (NN thymocyte) (NN development))))))
      (VP (VBP result)
        (PP (IN in)
          (NP
            (NP (JJ differential) (NNS effects))
            (PP (IN on)
              (NP (NNS TEC)
                (NP
                  (NP (NN differentiation))
                  (CC and)
                  (NP (NN function)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN Because)
        (PP (IN of)
          (NP
            (NP (DT the) (JJ complex) (NN interdependence))
            (PP (IN of)
              (NP
                (NP (NN TEC))
                (CC and)
                (NP (NN thymocyte) (NN differentiation)))))))
      (, ,)
      (NP
        (NP (NNS defects))
        (PP (IN in)
          (NP (JJ fetal) (NN TEC) (NN development))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN caused)
            (PP (CC either)
              (PP
                (ADVP (RB directly))
                (IN by)
                (NP (JJ cell-autonomous) (NN TEC) (NN differentiation) (NNS defects)))
              (, ,)
              (CC or)
              (ADVP (RB indirectly))
              (PP (IN by)
                (NP (JJ defective) (NN thymocyte) (NN maturation))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Once)
        (S
          (NP (DT a) (JJ mature) (JJ thymic) (NN environment))
          (VP (VBZ is)
            (VP (VBN formed)))))
      (, ,)
      (NP
        (NP
          (ADJP (JJ many)))
        (, ,)
        (CONJP (IN if) (RB not))
        (NP
          (NP (DT all) (NNS stages))
          (PP (IN of)
            (NP (NN thymocyte) (NN maturation)))))
      (VP (VBP require)
        (NP
          (NP (NNS interactions))
          (PP (IN with)
            (NP (JJ thymic) (JJ epithelial) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (NNS defects))
        (PP (IN in)
          (NP (NNS TECs))))
      (VP (MD can)
        (VP
          (PP (IN in)
            (NP (NN turn)))
          (VB cause)
          (NP
            (NP (NNS defects))
            (PP (IN in)
              (NP
                (NP (NN thymocyte) (NN differentiation))
                (, ,)
                (NP (NN proliferation))
                (, ,)
                (CC or)
                (NP (NN cell) (NN death))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Thymocyte) (NN differentiation))
      (VP (VBZ undergoes)
        (NP (CD two) (JJ main) (NNS transitions))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ first))
      (VP (VBZ is)
        (PP (IN from)
          (NP
            (NP
              (NP (DT the) (JJ CD3-4-8-))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (JJ triple) (JJ negative))
                  (, ,)
                  (NP (NN TN)))
                (-RRB- -RRB-)))
            (PP (TO to)
              (NP (DT the)
                (ADJP
                  (ADJP (JJ CD4+8+))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (ADJP (JJ double) (JJ positive))
                      (, ,) (NN DP))
                    (-RRB- -RRB-)))
                (NNS stages)))))))
    (. .)))

(
  (S
    (PP (IN During)
      (NP (DT this) (NN transition)))
    (, ,)
    (NP (NN T) (NN cell) (NNS precursors))
    (ADVP (RB sequentially))
    (VP
      (VP (VB gain))
      (CC and)
      (VP (VB lose)
        (NP
          (NP (NN cell) (NN surface) (NN expression))
          (PP (IN of)
            (NP
              (NP
                (NP (NN CD44))
                (CC and)
                (NP (NN CD25)))
              (NNS markers)))))
      (, ,)
      (VP (VB express)
        (NP
          (NP (DT the) (JJ pre-T) (NN cell) (NN receptor))
          (PRN (-LRB- -LRB-)
            (NP (NN pTCR))
            (-RRB- -RRB-))))
      (, ,)
      (CC and)
      (VP (VB undergo)
        (NP (NN β-selection) (CD -LSB-2,7-9) (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ other) (NN transition))
      (VP (VBZ is)
        (PP (IN from)
          (NP
            (NP (JJ CD4+8+) (NN DP))
            (PP (TO to)
              (NP
                (ADJP
                  (ADJP (JJ CD4+))
                  (CC or)
                  (ADJP
                    (ADJP (JJ CD8+)
                      (S
                        (NP
                          (NP (JJ single) (JJ positive) (-LRB- -LRB-) (NN SP) (-RRB- -RRB-) (NNS thymocytes))
                          (, ,)
                          (SBAR
                            (WHPP (IN in)
                              (WHNP (WDT which)))
                            (S
                              (NP (NN DP) (NNS cells))
                              (VP
                                (VP (VBP express)
                                  (NP (NN CD3)))
                                (, ,)
                                (VP (VBP rearrange)
                                  (NP (PRP$ their) (NN α-TCR)))
                                (, ,)
                                (VP (VBP undergo)
                                  (NP
                                    (ADJP
                                      (ADJP (JJ positive))
                                      (CC and)
                                      (ADJP (JJ negative)))
                                    (NN selection)))
                                (, ,)
                                (CC and)
                                (ADVP (RB down))
                                (VP (VBP regulate)
                                  (NP
                                    (NP (NN CD4))
                                    (CC or)
                                    (NP (NN CD8))))))))
                        (VP (TO to)
                          (VP (VB become)
                            (NP (JJ functional) (JJ CD8+))))))
                    (CC or)
                    (ADJP (JJ CD4+))))
                (NN SP) (NN T) (NNS cells)))))
        (NP (NN -LSB-10,11))
        (-RRB- -RSB-)))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN addition))
          (PP (TO to)
            (NP (JJ functional)
              (CC and)
              (NN cell) (NN surface) (NN marker) (NNS changes)))))
      (, ,)
      (NP (DT each) (NN thymocyte) (NN differentiation) (NN stage))
      (VP (VBZ is)
        (VP (VBN marked)
          (PP (IN by)
            (NP
              (NP (JJ characteristic) (NNS changes))
              (PP (IN in)
                (NP
                  (NP (NN proliferation))
                  (CC and)
                  (NP (NN apoptosis) (CD -LSB-12-18))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (ADJP (RBS most)
            (ADJP (RB well) (VBN defined)))
          (NN role))
        (PP (IN for)
          (NP (NN TECs)))
        (PP (IN in)
          (S
            (VP
              (ADVP (RB directly))
              (VBG affecting)
              (NP (NN thymocyte) (NN differentiation))))))
      (VP (VBZ is)
        (S
          (VP (TO to)
            (VP (VB mediate)
              (NP (JJ positive) (NN selection))
              (PP (IN via)
                (NP
                  (NP (NN expression))
                  (PP (IN of)
                    (NP (NN MHC) (NNS molecules) (CD -LSB-11,19-22) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (ADVP (RB still))
        (ADJP (JJ unclear))
        (SBAR
          (SBAR (IN whether)
            (S
              (NP (NNS TECs))
              (ADVP (RB directly))
              (VP (VBP promote)
                (NP
                  (NP (JJ specific) (NNS stages))
                  (PP (IN of)
                    (NP (NN thymocyte) (NN differentiation))))
                (PP (IN during)
                  (NP
                    (NP (NNS stages))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP do) (RB not)
                          (VP (VB involve)
                            (NP (NN MHC-TCR) (NNS interactions)))))))))))
          (, ,)
          (CC or)
          (SBAR (IN whether)
            (S
              (NP
                (NP (PRP$ their) (NN role))
                (PP (IN at)
                  (NP (JJ other) (NNS stages))))
              (VP (VBZ is)
                (ADVP (RB primarily))
                (S
                  (VP (TO to)
                    (VP (VB promote)
                      (NP
                        (NP (NN cell) (NN growth))
                        (CC and)
                        (NP (CC /or)
                          (NP (NN survival)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (NNS Cytokines))
          (VP (VBN produced)
            (PP (IN by)
              (NP (NNS TECs)))))
        (VP
          (VP (VBP have)
            (VP (VBN been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB promote)
                      (NP
                        (NP (NN proliferation))
                        (PP (IN in)
                          (NP
                            (NP (JJ early) (NNS stages))
                            (PP (IN of)
                              (NP (NN thymocyte) (NN development))))))))))))
          (, ,)
          (CC and)
          (VP (VBP have)
            (VP (VBN been)
              (VP (VBN proposed)
                (S
                  (VP (TO to)
                    (VP (VB regulate)
                      (NP
                        (NP (NN apoptosis))
                        (CC and)
                        (NP (NN differentiation)))))))))))
      (, ,) (IN although)
      (S
        (NP (PRP$ their) (JJ precise) (NNS roles))
        (VP (VBP remain)
          (ADJP (JJ controversial)
            (NP (CD -LSB-23,24) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (NNS TECs))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB promote)
                  (NP (NN thymocyte) (NN proliferation))
                  (PP (IN in)
                    (NP (NN SP) (NNS cells))))
                (SBAR (IN after)
                  (S
                    (NP (NN selection))
                    (VP (VBZ has)
                      (VP (VBN occurred)
                        (S
                          (NP (NN -LSB-15))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (DT a) (VBN defined) (NN role))
        (PP (IN for)
          (NP (NNS TECs)))
        (PP (IN at)
          (NP (DT the) (NN TN-DP) (NN transition))))
      (VP (VBZ remains)
        (ADJP (JJ elusive))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Much))
        (PP (IN of)
          (NP
            (NP (DT the) (NN research))
            (PP (IN on)
              (NP (DT this) (NN transition))))))
      (VP (VBZ has)
        (VP (VBN focused)
          (PP (IN on)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (DT the) (NN pre-TCR))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Mounting) (NN evidence))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (S
              (NP (DT the) (NN pre-TCR))
              (VP (VBZ does) (RB not)
                (VP (VB require)
                  (NP
                    (NP (NN interaction))
                    (PP (IN with)
                      (NP (DT a) (NN ligand)))
                    (S
                      (VP (TO to)
                        (VP (VB perform)
                          (NP (PRP$ its) (NN function)))))))))
            (, ,)
            (CC and)
            (S
              (NP
                (NP
                  (NP (DT the) (JJ subsequent) (NN CD44-25-))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN TN4))
                      (CC or)
                      (NP (NN pre-DP)))
                    (-RRB- -RRB-)))
                (PP (TO to)
                  (NP (NN DP) (NN transition))))
              (VP (VBZ has)
                (VP (VBN been)
                  (VP (VBN termed)
                    (S (`` ``)
                      (NP
                        (NP (VBN programmed) (NN differentiation) (NN ''))
                        (S
                          (VP (TO to)
                            (VP (VB indicate)
                              (SBAR (IN that)
                                (S
                                  (NP (DT this) (NN step))
                                  (VP (MD can)
                                    (VP (VB occur)
                                      (PP (IN in)
                                        (NP (VBN isolated) (NNS thymocytes)))
                                      (, ,)
                                      (PP
                                        (ADVP (RB presumably))
                                        (IN without)
                                        (NP
                                          (NP (NN input))
                                          (PP (IN from)
                                            (NP
                                              (NP (JJ extrinsic) (NNS signals))
                                              (CD -LSB-25-27) (-RRB- -RSB-))))))))))))))))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (ADVP (RB also))
      (NP (NN evidence)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ thymic) (NN microenvironment))
            (VP (VBZ does)
              (VP (VB contribute)
                (NP
                  (NP (NNS signals))
                  (VP (VBN required)
                    (PP (IN for)
                      (NP (DT the) (NN TN-DP) (NN transition))))))))))
      (, ,)
      (S
        (ADVP (RB particularly))
        (VP (TO to)
          (VP (VB promote)
            (NP
              (NP (NN thymocyte) (NN proliferation))
              (CC and)
              (NP (NN apoptosis) (CD -LSB-13,28-30) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (NP (JJ specific) (NN nature))
          (CC and)
          (NP (NN purpose)))
        (PP (IN of)
          (NP (DT the) (NN TEC) (NN contribution)))
        (PP (IN during)
          (NP (DT this) (JJ important) (NN transition))))
      (ADVP (RB therefore))
      (VP (VBZ remains)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN determined)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN In) (NN order)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP (NN thymocyte) (NN development)))
                (PP (IN by)
                  (NP (NNS TECs))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBP are)
        (VP (VBG studying)
          (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NNS mice)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Hoxa3))
        (CC and)
        (NP (NN Pax1)))
      (VP (VBP are)
        (NP
          (NP (NN transcription) (NNS factors))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP act)
                (PP (IN in)
                  (NP
                    (NP (DT a) (JJ common) (NN pathway))
                    (VP (VBG regulating)
                      (NP
                        (NP (NN thymus) (NN organogenesis))
                        (CC and)
                        (NP (JJ thymic) (NN epithelial) (NN cell) (NN development) (CD -LSB-29,31-34)))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))
      (VP (VBP have)
        (NP
          (NP
            (NP (NNS defects))
            (PP (IN in)
              (NP (NN TEC) (NN development)))
            (PP (VBG including)
              (NP
                (NP (VBN reduced) (NNS numbers))
                (PP (IN of)
                  (NP (NNS TECs))))))
          (, ,)
          (NP (JJR fewer) (NN MHC) (NN Class) (JJ II+) (NNS TECs))
          (, ,)
          (CC and)
          (NP
            (NP (NNS changes))
            (PP (IN in)
              (NP
                (NP (NN TEC) (NN proliferation))
                (CC and)
                (NP (NN apoptosis))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NN TEC) (NNS defects))
      (VP (VBP result)
        (PP (IN in)
          (NP
            (NP (NN thymocyte) (NN maturation) (NNS defects))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP include)
                  (NP
                    (NP
                      (NP (DT a) (NN decrease))
                      (PP (IN in)
                        (NP (JJ total) (NN thymocyte) (NN number))))
                    (CC and)
                    (NP
                      (NP (DT a) (JJ 10-fold) (NN reduction))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN number))
                          (PP (IN of)
                            (NP (NN DP) (NNS thymocytes))))))
                    (, ,)
                    (CC but)
                    (NP
                      (NP (DT an)
                        (ADJP (RB apparently) (JJ normal))
                        (NN transition))
                      (PP (IN from)
                        (NP (DT the) (NN TN3)))
                      (PP (TO to)
                        (NP (DT the) (NN pre-DP) (NN stage))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN decrease))
        (PP (IN in)
          (NP (NN DP) (NNS cells))))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN increased) (NN apoptosis))
              (PP (IN in)
                (NP (CC both)
                  (NP (NN pre-DP))
                  (CC and)
                  (NP (NN DP) (NNS cells))
                  (NP (NN -LSB-29))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (NP
            (NP (DT the) (NNS defects))
            (PP (IN at)
              (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)))
            (PP (IN in)
              (NP (DT these) (NNS mutants))))
          (VP (VBP are)
            (VP (VBN caused)
              (PP (IN by)
                (NP
                  (NP (JJ defective) (NN TEC) (NN function))
                  (CONJP (RB rather) (IN than))
                  (NP (JJ thymocyte-intrinsic) (NNS defects))))))))
      (, ,)
      (NP (DT these) (NNS mice))
      (VP (VBP represent)
        (NP
          (NP (DT an) (NN opportunity))
          (S
            (VP (TO to)
              (VP (VB study)
                (NP
                  (NP (DT the) (NN role))
                  (PP (IN of)
                    (NP (NNS TECs)))
                  (PP (IN in)
                    (S
                      (VP (VBG promoting)
                        (NP (DT this) (NN transition))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB further))
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (NNS TECs)))
              (PP (IN in)
                (S
                  (VP (VBG promoting)
                    (NP
                      (NP (NN thymocyte) (NN death))
                      (CC and)
                      (NP (NN growth)))
                    (PP (IN during)
                      (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))))))))))
      (, ,)
      (S
        (NP (PRP we))
        (VP (VBD assayed)
          (NP
            (NP (DT the) (NN proliferation))
            (PP (IN of)
              (NP
                (NP (JJ specific) (NN thymocyte) (NNS subsets))
                (VP (VBG using)
                  (NP
                    (NP (NN BrdU) (NN incorporation))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBZ detects)
                          (NP (NN cycling) (NNS cells))
                          (PP (IN in)
                            (NP (NN S-phase))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD compared)
        (NP
          (NP
            (ADJP
              (ADJP (JJ fetal))
              (CC and)
              (ADJP (JJ adult)))
            (JJ wild) (NN type) (NNS mice))
          (PP (IN with)
            (NP (NN Hoxa3)))
          (PRN (, ,)
            (S
              (NP (NN Pax1) (NN compound) (NNS mutants))
              (NP (NN -LSB-29,34)))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD assayed)
        (NP
          (NP (JJ Rag1-/-) (NNS mice))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP have)
                (NP
                  (NP (NNS defects))
                  (PP (IN in)
                    (NP
                      (NP (NN TEC) (NN development))
                      (ADJP (JJ due)
                        (PP (TO to)
                          (NP (VBN arrested) (NN thymocyte) (NN maturation)))))))
                (PP (IN at)
                  (NP (DT the) (NN TN3) (NN stage) (CD -LSB-35))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (NP
          (NP (JJ stage-specific) (NNS differences))
          (PP (IN in)
            (NP (NN proliferation) (NNS levels)))
          (PP (IN between)
            (NP
              (ADJP
                (ADJP (JJ fetal))
                (CC and)
                (ADJP (JJ adult)))
              (JJ wild) (NN type) (NNS thymocytes))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VBD found)
      (NP
        (NP (JJ distinct) (NNS patterns))
        (PP (IN of)
          (NP (NN thymocyte) (NN proliferation)))
        (PP (IN in)
          (NP (DT the)
            (ADJP
              (ADJP (JJ Rag1-/-))
              (CC and)
              (ADJP (JJ Hoxa3)))
            (, ,)
            (NP (NN Pax1) (NNS mutants))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (NP
            (NP (JJ abnormal) (NN cell) (NN death))
            (CC and)
            (NP (NN proliferation)))
          (NNS patterns))
        (PP (IN in)
          (NP
            (NP
              (NP (DT the) (NN Hoxa3))
              (, ,)
              (NP (NN Pax1) (NN compound)))
            (JJ mutant) (JJ fetal) (NNS thymocytes))))
      (VP (MD might)
        (VP (VB be)
          (VP (VBN caused)
            (PP (IN in)
              (NP (NN part)))
            (PP (IN by)
              (NP
                (NP (VBN observed) (NNS reductions))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN transcription) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NNS cytokines))
                        (NP
                          (NP (NN IL-7))
                          (CC and)
                          (NP (NN SCF)))
                        (VP (VBN produced)
                          (PP (IN by)
                            (NP (NNS TECs))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP
        (VP (VBP support)
          (NP
            (NP (DT a) (JJ critical) (NN role))
            (PP (IN for)
              (NP
                (NP (NN microenvironment))
                (VP (VBN created)
                  (PP (IN by)
                    (NP (NNS TECs))))))
            (PP (IN in)
              (S
                (VP (VBG regulating)
                  (NP (NN thymocyte) (NN proliferation))
                  (PP (IN during)
                    (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))))))))
        (, ,)
        (CC and)
        (VP (VBP show)
          (SBAR (IN that)
            (S
              (NP (DT this) (NN function))
              (VP (VBZ is)
                (VP (VBN disrupted)
                  (PP (IN in)
                    (NP
                      (NP (NN Hoxa3))
                      (, ,)
                      (NP (NN Pax1) (NN compound) (NNS mutants)))))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (PP (IN As)
      (NP (DT an) (JJ initial) (NN analysis)))
    (, ,)
    (NP (PRP we))
    (VP (VBD compared)
      (NP (NN thymocyte) (NN proliferation))
      (PP (IN between)
        (NP
          (NP (NNS thymocytes))
          (PP (IN from)
            (NP
              (ADJP
                (ADJP (JJ late) (JJ fetal))
                (PRN (-LRB- -LRB-)
                  (NP (NN E17.5))
                  (-RRB- -RRB-))
                (CC and)
                (ADJP (JJ adult))
                (PRN (-LRB- -LRB-)
                  (NP (CD 6–8) (NN week))
                  (-RRB- -RRB-)))
              (JJ wild) (NN type) (JJ C57BL6/J) (NNS mice))))))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (NNS differences))
          (PP (IN in)
            (NP
              (NP (DT the) (NN proliferation))
              (PP (IN of)
                (NP
                  (ADJP
                    (ADJP (JJ fetal))
                    (CC vs.)
                    (ADJP (JJ adult)))
                  (JJ TCR-expressing) (NNS thymocytes))))))
        (CC and)
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN reported)
              (NP (CD -LSB-36) (-RRB- -RSB-)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD were)
      (ADJP (JJ interested)
        (PP (IN in)
          (S
            (VP (VBG investigating)
              (NP (DT the)
                (ADJP (RBR more) (JJ immature))
                (NN thymocyte) (NNS subsets)))))))
    (. .)))

(
  (S
    (S
      (NP (NN BrdU) (VBN labeled)
        (ADJP
          (ADJP (JJ fetal))
          (CC and)
          (ADJP (JJ adult)))
        (NNS thymi))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (DT the) (NN percent))
              (PP (IN of)
                (NP (VBG proliferating) (NNS cells)))))
          (PP (IN in)
            (NP
              (NP (JJ different) (JJ CD3-4-8-) (NN TN) (NN thymocyte) (NNS subsets))
              (VP (VBN defined)
                (PP (IN by)
                  (NP
                    (NP (NN CD44))
                    (CC and)
                    (NP (NN CD25))
                    (NP (NN expression) (NN -LSB-8))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ CD3+4+8+) (NN population))
      (VP (VBD was)
        (VP (VBN defined)
          (PP (IN by)
            (NP
              (NP (NN co-staining))
              (PP (IN of)
                (NP
                  (NP (DT all) (CD three) (NNS markers))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (NN 1A))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ typical) (NN analysis))
        (PP (IN of)
          (NP
            (NP
              (NP (DT the) (NN BrdU+) (NNS cells))
              (PP (IN in)
                (NP (NN DP) (NNS cells))))
            (CC and)
            (NP
              (NP (DT the) (CD four)
                (NP
                  (NP (NN CD44))
                  (CC vs.)
                  (NP (NN CD25)))
                (NNS subsets))
              (PP (IN within)
                (NP (DT the) (NN TN) (NN cell) (NN population)))))))
      (VP (VBZ is)
        (VP (VBN shown)
          (PP (IN in)
            (NP (NN Figure) (CD 1))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Compiled) (NN data))
        (PP (IN for)
          (NP
            (NP (DT each) (NN subset))
            (PP (IN from)
              (NP (DT all) (NNS experiments))))))
      (VP (VBZ is)
        (VP (VBN shown)
          (PP (IN in)
            (NP (NN Table) (CD 1))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (DT The) (JJ wild) (NN type))
            (ADJP
              (ADJP (JJ adult)
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Fig.) (CD 1C))
                    (, ,)
                    (NP (NN 1F)))
                  (-RRB- -RRB-)))
              (CC and)
              (ADJP (JJ fetal))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Fig.) (CD 1D))
              (, ,)
              (NP (NN 1F)))
            (-RRB- -RRB-)))
        (NN thymocyte) (NN proliferation) (NN profile) (NNS patterns))
      (VP (VBD differed)
        (ADVP (RB significantly))
        (PP (IN at)
          (NP (JJ specific) (NNS stages)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ overall) (NN proliferation) (NN level))
        (PP (IN in)
          (NP (NN TN) (NNS cells))))
      (VP (VBD was)
        (VP (VBN increased)
          (PP (IN by)
            (NP (CD 50) (NN %)))
          (PP (IN in)
            (NP (JJ fetal) (NNS thymocytes)))
          (PRN (-LRB- -LRB-)
            (NP (NN p) (NN <) (CD 0.01))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (ADVP (RBS Most) (RB dramatically))
      (, ,)
      (NP
        (NP (DT the) (NNS percentages))
        (PP (IN of)
          (NP (NN BrdU+) (NNS cells)))
        (PP (IN in)
          (NP (JJ fetal) (NNS thymocytes))))
      (VP (VBD were)
        (ADJP
          (ADJP (RB 10-fold) (JJR higher))
          (PP (IN than)
            (PP (IN in)
              (NP (DT the) (NN adult))))
          (PP (IN at)
            (NP
              (NP (DT the) (JJS earliest) (, ,) (NN TN1) (-LRB- -LRB-) (CD CD44+25-) (-RRB- -RRB-) (NN thymocyte) (NN differentiation) (NN stage))
              (PRN (-LRB- -LRB-)
                (NP (NN P) (NN <) (CD 0.001))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT A)
        (ADJP
          (ADJP (RB much) (JJR lower))
          (, ,)
          (CC but)
          (ADJP
            (ADVP (RB still))
            (JJ significant)))
        (NN increase))
      (VP (VBD was)
        (VP (VBN seen)
          (PP (IN in)
            (NP (JJ fetal) (NN TN2) (NNS cells)))
          (PRN (-LRB- -LRB-)
            (NP (CD 25) (NN %) (NN increase))
            (, ,)
            (NP (NN p) (NN <) (CD 0.01))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN Proliferation))
      (VP (VBD was)
        (ADVP (RB also))
        (ADJP
          (ADJP (RB significantly) (JJR higher))
          (PP (IN at)
            (NP (DT the) (JJ fetal) (NN TN3) (NN stage)))
          (PP (VBN compared)
            (PP (TO to)
              (NP (NN adult)))))
        (PRN (-LRB- -LRB-)
          (NP
            (ADJP (CD 50) (NN %))
            (NN increase))
          (, ,)
          (NP (NN p) (JJ <) (CD 0.01))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Proliferation))
        (PP (IN at)
          (NP (DT the) (NN TN4/pre-DP) (-LRB- -LRB-) (CD CD44-25-) (-RRB- -RRB-) (NN stage))))
      (VP (VBD was)
        (ADJP (JJ similar)
          (PP (IN between)
            (NP
              (ADJP
                (ADJP (JJ fetal))
                (CC and)
                (ADJP (JJ adult)))
              (NNS thymocytes))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (NN DP) (NNS cells))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ 3-fold) (NN increase))
        (PP (IN in)
          (NP (NN proliferation)))
        (PP (IN in)
          (NP (DT the) (JJ fetal) (NN thymus))))
      (ADVP (JJ relative)
        (PP (TO to)
          (NP (NN adult)))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN p))
            (QP (RB <) (CD 0.01)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (RB nearly) (DT every) (NN stage))
        (PP (IN from)
          (NP
            (NP (DT the) (JJS earliest) (NN TN))
            (PP (TO to)
              (NP (DT the) (NN DP) (NNS stages))))))
      (VP (VBD showed)
        (NP
          (NP
            (ADJP (RB significantly) (VBN increased))
            (NN proliferation))
          (PP (IN in)
            (NP (JJ fetal) (NNS thymocytes))))
        (ADVP (JJ relative)
          (PP (TO to)
            (NP (NNS adults))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBD was)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJR lower) (NN percentage))
              (PP (IN of)
                (NP
                  (NP (VBG proliferating) (NNS cells))
                  (VP (VBN seen)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN TN1) (NN population))
                        (PP (IN in)
                          (NP (NNS adults)))))))))
            (VP (VBD was)
              (ADJP (JJ due)
                (PP (TO to)
                  (NP
                    (NP (DT an) (VBN increased) (NN number))
                    (PP (IN of)
                      (NP
                        (NP (NN B) (NNS cells))
                        (CC and)
                        (NP (NN NK) (NNS cells)))))))
              (PP (IN in)
                (NP (DT the) (JJ adult) (NN thymus)))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (MD would) (RB not)
                    (VP (VBP have)
                      (VP (VBN been)
                        (VP (VBN excluded)
                          (PP (IN in)
                            (NP (PRP$ our) (JJ initial) (NN analysis))))))))))))))
    (. .)))

(
  (S
    (SBAR (IN As)
      (S
        (NP (DT this))
        (VP (VBD was)
          (NP
            (NP (CD one))
            (PP (IN of)
              (NP
                (NP (DT the)
                  (ADJP (RBS most) (JJ striking))
                  (NNS differences))
                (VP (VBN seen)
                  (PP (IN between)
                    (NP
                      (ADJP
                        (ADJP (JJ fetal))
                        (CC and)
                        (ADJP (JJ adult)))
                      (NNS stages))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBN repeated)
      (NP (DT this) (NN analysis))
      (S
        (VP (VBG adding)
          (NP
            (NP (NNS antibodies))
            (PP (IN against)
              (NP
                (NP
                  (NP (NN B220))
                  (CC and)
                  (NP (CD NK1.1) (TO to) (NN CD3)))
                (, ,)
                (NP
                  (NP (CD 4))
                  (CC and)
                  (NP (CD 8))))))
          (PP (IN in)
            (NP
              (NP (DT the) (VBN excluded) (NN gate))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Fig.) (NN 1G))
                  (, ,)
                  (NP (NN 1H)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (VP
        (ADVP (RB Even))
        (VBG excluding)
        (NP (DT these) (NN cell) (NNS populations))))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (ADVP (RB still))
      (NP
        (NP (DT a)
          (ADJP (RB significantly) (JJR lower))
          (NN percentage))
        (PP (IN of)
          (NP (VBG proliferating) (NNS cells)))
        (PP
          (PP (IN in)
            (NP
              (NP (DT the) (NN TN1) (NN population))
              (PP (IN in)
                (NP (DT the) (JJ adult) (NN thymus)))))
          (CONJP (IN than))
          (PP (IN in)
            (NP (DT the) (JJ fetal) (NN thymus))))))
    (PRN (-LRB- -LRB-)
      (NP (NNP Fig.) (CD 1I))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP (DT this) (NN difference))
      (VP (VBZ is) (RB not)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (JJ different) (NNS numbers))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP (NN B))
                      (CC and)
                      (NP (NN NK)))
                    (NNS cells))
                  (PP (IN in)
                    (NP (DT the)
                      (ADJP
                        (ADJP (JJ adult))
                        (CC vs.)
                        (ADJP (JJ fetal)))
                      (NN thymus))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD compared)
        (NP
          (NP (NN proliferation))
          (PP (IN of)
            (NP (JJ fetal) (NNS thymocytes))))
        (PP (IN from)
          (NP (JJ Rag1-/-) (NNS mice)))
        (PP (TO to)
          (NP
            (NP (DT the) (NNS results))
            (VP (VBN obtained)
              (PP (IN from)
                (NP (JJ wild) (NN type) (NNS mice))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Thymocytes))
        (PP (IN in)
          (NP (DT the) (JJ adult) (JJ Rag1-/-) (NN thymus))))
      (VP (VBP have)
        (VP (VBN been)
          (ADVP (RB previously))
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP
                    (NP
                      (ADJP (RB overall) (JJR lower))
                      (NNS levels))
                    (PP (IN of)
                      (NP (NN proliferation))))
                  (PP (IN than)
                    (NP
                      (NP (JJ adult) (JJ wild) (NN type))
                      (NP (NN TN) (NNS thymocytes) (CD -LSB-13) (-RRB- -RSB-))))
                  (, ,)
                  (PP
                    (ADVP (RB particularly))
                    (IN at)
                    (NP (DT the) (NN TN3) (NN stage) (CD -LSB-37-40) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP (JJ fetal) (NNS stages)))
      (, ,)
      (NP (PRP$ our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (NN proliferation))
            (ADVP (RB also))
            (VP (VBD varied)
              (PP (IN between)
                (NP (NNS thymocytes)))
              (PP (IN in)
                (NP (DT the)
                  (NP (JJ wild) (NN type))
                  (CC and)
                  (NP (JJ Rag1-/-) (NN thymus))))
              (PP (IN at)
                (NP
                  (NP (JJ discrete) (NNS stages))
                  (PP (IN of)
                    (NP (NN thymocyte) (NN differentiation))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP (DT the) (JJS earliest) (NN TN1) (NN stage)))
      (, ,)
      (NP
        (NP
          (NP (NN thymocyte) (NN proliferation))
          (NNS levels))
        (PP (IN in)
          (NP (JJ Rag1-/-) (NNS thymi))))
      (VP (VBD were)
        (ADJP (JJ similar)
          (PP (TO to)
            (NP (JJ fetal) (JJ wild) (NN type) (NNS cells))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP Fig.))
            (NP (NN 1E)))
          (, ,)
          (NP
            (NP (NN 1F))
            (: ;)
            (NP (NN Table) (CD 1)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP (DT the) (NN TN2) (NN stage)))
      (, ,)
      (NP
        (NP (JJ fetal) (NNS thymocytes))
        (PP (IN from)
          (NP (JJ Rag1-/-) (NNS mice))))
      (VP (VBD had)
        (NP
          (NP (DT a) (NN proliferation) (NN level))
          (PP
            (CONJP (RB nearly) (RB twice) (IN that))
            (PP (IN of)
              (NP (JJ wild) (NN type)
                (NP
                  (NP (JJ fetal) (NNS thymocytes))
                  (PRN (-LRB- -LRB-)
                    (NP (NN p) (NN <) (CD 0.001))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (PP (IN By)
      (NP (DT the) (NN TN3) (NN stage)))
    (, ,)
    (NP
      (NP (DT the) (NN percentage))
      (PP (IN of)
        (NP (VBG proliferating) (JJ Rag1-/-) (NNS thymocytes))))
    (VP (VBD had)
      (VP (VBD dropped)
        (ADVP (RB slightly))
        (PP (IN below)
          (NP
            (NP (DT that))
            (PP (IN of)
              (NP
                (NP (JJ wild) (NN type))
                (JJ fetal) (NNS thymocytes)))))
        (PRN (-LRB- -LRB-)
          (NP (CD ~30) (NN %) (NN decrease))
          (, ,)
          (NP (NN p) (NN <) (CD 0.01))
          (-RRB- -RRB-))
        (, ,)
        (NP
          (ADJP (JJ equal)
            (PP (TO to)
              (NP (JJ wild) (NN type))))
          (NP (JJ adult) (NN TN3) (NN proliferation))
          (NNS levels))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NNS percentages))
      (PP (IN of)
        (NP (NN BrdU+) (NNS cells)))
      (PP (IN in)
        (NP
          (NP
            (NP
              (NP (NN TN1))
              (CC and)
              (NP (NN TN2)))
            (NNS subsets))
          (PP (IN in)
            (NP (DT the) (JJ Rag1-/-) (JJ fetal) (NN thymus))))))
    (VP (VBD were)
      (ADJP
        (ADJP (RB significantly) (JJR higher))
        (PP (IN than)
          (NP
            (NP (DT those))
            (PP (IN of)
              (NP (DT the) (JJ wild) (NN type)
                (NP
                  (NP (NNS adults))
                  (PRN (-LRB- -LRB-)
                    (NP (NN P) (NN <) (CD 0.001))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (NP
      (NP (DT These) (NNS results))
      (PP (IN with)
        (NP (JJ Rag1-/-) (JJ fetal) (NNS thymocytes))))
    (VP (NN contrast)
      (PP (IN with)
        (NP (NNS thymocytes)))
      (PP (IN in)
        (NP
          (NP (DT the) (JJ Rag-/-) (NN adult))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP have)
                (NP
                  (NP
                    (ADJP (RB much) (JJR lower))
                    (NN proliferation))
                  (PP (IN than)
                    (NP
                      (NP (JJ wild) (NN type))
                      (JJ adult) (NNS thymocytes))))
                (PP (IN at)
                  (NP
                    (NP (DT all) (NNS stages))
                    (PP (IN of)
                      (NP (NN thymocyte) (NN differentiation) (CD -LSB-13) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (NP
      (NP (PRP$ Our) (JJ previous) (NN analysis))
      (PP (IN of)
        (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NN thymocyte) (NN phenotype))))
    (VP (VBD showed)
      (NP
        (NP
          (NP (DT a) (JJ specific) (JJ partial) (NN block))
          (PP (IN at)
            (NP
              (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))
              (, ,)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN increased) (NN apoptosis))
                    (PP (IN at)
                      (NP (CC both)
                        (DT the)
                        (NP
                          (NP (NN TN4/pre-DP))
                          (CC and)
                          (NP (NN DP)))
                        (NNS subsets))))))
              (, ,))))
        (CC and)
        (NP
          (NP (DT a) (JJ 10-fold) (NN decrease))
          (PP (IN in)
            (NP (NN DP) (NN cell) (NNS numbers))))
        (NP (CD -LSB-29) (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Using)
          (NP (NN BrdU) (NN analysis))))
      (, ,)
      (NP (PRP we))
      (VP (VBD compared)
        (NP
          (NP (DT the) (NN proliferation))
          (PP (IN of)
            (NP (JJ Hoxa3+/-Pax1-/-) (JJ fetal) (NNS thymocytes))))
        (PP (IN during)
          (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)))
        (PP (VBN compared)
          (PP (TO to)
            (NP (JJ littermate) (NNS controls))))))
    (. .)))

(
  (S
    (NP
      (NP
        (NP (NN Thymocyte) (NN proliferation) (NNS levels))
        (PP (IN for)
          (NP
            (NP
              (NP (DT all) (NNS genotypes))
              (PRN (-LRB- -LRB-)
                (ADJP
                  (ADJP (JJ Hoxa3+/-))
                  (, ,)
                  (ADJP (JJ Pax1+/-))
                  (, ,)
                  (ADJP (JJ Pax1-/-))
                  (, ,)
                  (CC and)
                  (ADJP (JJ Hoxa3+/-Pax1-/-)))
                (-RRB- -RRB-)))
            (VP (VBD were)
              (ADJP (JJ similar)
                (PP (TO to)
                  (NP (JJ wild) (NN type)))
                (PP (IN in)
                  (NP
                    (NP (DT all))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (JJ canonical) (NN TN1-TN4) (NNS stages))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Fig.) (CD 2A,2B,2C))
                          (: ;)
                          (NP (NN Table) (CD 1))
                          (-RRB- -RRB-)))))))
              (, ,)
              (ADJP (JJ consistent)
                (PP (IN with)
                  (NP (DT the) (JJ normal) (NNS percentages))))))))
      (CC and)
      (NP
        (NP (NN cell) (NNS numbers))
        (PP (IN for)
          (NP (DT these) (NNS subpopulations)))))
    (ADVP (RB previously))
    (VP (VBD reported)
      (NP (CD -LSB-29) (-RRB- -RSB-)))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Recent) (NNS papers))
        (PP (IN by)
          (NP
            (NP (NNP Penit))
            (, ,)
            (ADVP (FW et) (FW al.)))))
      (VP (VBP have)
        (VP (VBN provided)
          (NP
            (NP (NNS data))
            (PP (IN from)
              (NP (NN cell) (NN cycle) (NN analysis))))
          (S
            (VP (VBG suggesting)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (DT a) (JJ discrete) (NN CD44-25lo) (NN population))
                    (PP (IN with)
                      (NP (DT a) (JJ specific) (NN proliferation) (NN profile))))
                  (VP (MD can)
                    (VP (VB be)
                      (VP (VBN identified) (, ,)
                        (SBAR (JJ such) (IN that)
                          (S
                            (NP
                              (NP (DT the) (NN transition))
                              (PP (IN from)
                                (NP (NN TN3)))
                              (PP (TO to)
                                (NP (NN DP))))
                            (VP (MD can)
                              (VP (VB be)
                                (ADVP (RB further))
                                (VP (VBN subdivided)
                                  (PP (IN into)
                                    (NP
                                      (NP
                                        (NP (NNP CD25hi))
                                        (, ,)
                                        (NP (NNP CD25lo))
                                        (, ,)
                                        (CC and)
                                        (NP (JJ CD25-) (NNS subsets)))
                                      (NP (CD -LSB-12,13) (-RRB- -RSB-)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Analysis))
        (PP (IN of)
          (NP (NN proliferation)))
        (VP (VBG using)
          (NP (DT these)
            (ADJP
              (ADVP (RBR more) (RB narrowly))
              (VBN defined))
            (NNS subsets))))
      (ADVP (RB still))
      (VP (VBD showed)
        (NP
          (NP (NNS values))
          (ADJP (JJ similar)
            (PP (TO to)
              (NP (JJ wild) (NN type)))))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ CD44-25lo) (NN subset))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Fig.) (NN 2D,2E,2F))
                (: ;)
                (NP (NN Table) (CD 2)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (NN proliferation) (NN level))
      (PP (IN of)
        (NP (NN DP) (NNS cells))))
    (VP (VBD increased)
      (ADVP (RB nearly) (RB 2-fold))
      (PP (IN in)
        (NP (NN compound) (NNS mutants)))
      (PP (VBN compared)
        (PP (TO to)
          (NP (JJ wild) (NN type))))
      (PRN (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 2C))
        (, ,)
        (NP
          (NP (NN 2F))
          (: ;)
          (NP (NN Table) (CD 1)))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (PP (IN In)
      (NP
        (NP (NN spite))
        (PP (IN of)
          (NP
            (NP (DT this) (NN increase))
            (PP (IN in)
              (NP
                (NP (DT the) (NN percentage))
                (PP (IN of)
                  (NP (VBG proliferating) (NNS cells)))))))))
    (, ,)
    (NP
      (NP (DT the) (JJ actual) (NN number))
      (PP (IN of)
        (NP (NN BrdU+) (NN DP) (NNS cells))))
    (VP (VBD was)
      (VP (VBN reduced)
        (ADVP (RB 4-fold))
        (PP (VBN compared)
          (PP (TO to)
            (NP (JJ wild) (NN type))))
        (PP (IN in)
          (NP (DT the) (JJ compound) (NNS mutants)))))
    (PRN (-LRB- -LRB-)
      (NP (CD 15.03) (NN ±) (NN 8.73) (NN ×) (CD 104)
        (CC vs.)
        (CD 61.94)))))

(
  (S
    (S
      (S
        (NP (NN ±) (CD 32.12))
        (VP (JJ ×)
          (NP (CD 104))
          (PP (IN in)
            (NP (JJ wild) (NN type)))))
      (: ;)
      (S
        (NP (NN p))
        (VP (JJ <)
          (NP (CD 0.01) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS numbers))
        (PP (IN of)
          (NP (VBG proliferating) (NNS cells)))
        (PP (IN at)
          (NP (DT the) (NN pre-DP) (NN stage))))
      (VP (VBD were)
        (ADJP
          (ADJP (JJ unchanged))
          (PRN (-LRB- -LRB-)
            (ADVP (RB not))
            (VP (VBN shown))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (VP (VBN Combined)
        (PP (IN with)
          (NP (PRP$ our) (JJ previous) (NNS results)))))
    (, ,)
    (NP (DT this) (NN result))
    (VP (VBZ shows)
      (SBAR (IN that)
        (S
          (NP (CC both)
            (NP (VBN increased) (NN apoptosis))
            (CC and)
            (NP (VBN reduced) (NN proliferation)))
          (VP (VBP contribute)
            (PP (TO to)
              (NP
                (NP (DT the) (NN decrease))
                (PP (IN in)
                  (NP
                    (NP (NN DP) (NNS cells))
                    (PP (IN in)
                      (NP (DT the) (NN Hoxa3) (, ,) (NN Pax1) (JJ compound) (NNS mutants)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Unfortunately))
      (, ,)
      (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice))
      (VP (VBP die)
        (PP (IN at)
          (NP (NN birth)))
        (, ,)
        (S
          (VP (VBG preventing)
            (NP
              (NP (NN analysis))
              (PP (IN of)
                (NP
                  (NP (NN thymocyte) (NN proliferation))
                  (PP (IN in)
                    (NP (JJ adult) (NN compound) (NNS mutants))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Cytokines))
        (VP (VBN produced)
          (PP (IN by)
            (NP (NNS TECs)))))
      (VP (VBP are)
        (NP
          (NP (JJ good) (NNS candidates))
          (PP (IN for)
            (S
              (VP (VBG mediating)
                (NP
                  (NP
                    (NP
                      (ADVP (IN at) (JJS least))
                      (DT some))
                    (PP (IN of)
                      (NP
                        (NP (DT these) (NNS changes))
                        (PP (IN in)
                          (NP
                            (NP
                              (NP (NN thymocyte) (NN proliferation))
                              (CC and)
                              (NP (NN apoptosis)))
                            (PP (IN in)
                              (NP (DT the) (NN Hoxa3))))))))
                  (, ,)
                  (NP (NN Pax1) (NN compound) (NNS mutants)))))))))
    (. .)))

(
  (S
    (S
      (VP (VBG Using)
        (NP (JJ semi-quantitative) (NN RT-PCR))))
    (, ,)
    (NP (PRP we))
    (VP (VBD analyzed)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP
              (NP (CD two) (NNS cytokines))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP are)
                    (VP (VBN produced)
                      (PP (IN by)
                        (NP (NNS TECs))))))))
            (, ,)
            (NP
              (NP (NN IL-7))
              (CC and)
              (NP (NN SCF)))
            (, ,)))
        (PP (IN in)
          (NP
            (NP
              (ADJP
                (ADJP (JJ pooled))
                (, ,)
                (ADJP (JJ genotype-matched)))
              (NN E14.5) (NNS thymi))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 3))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))
      (VP (VBD had)
        (NP
          (NP (VBN decreased) (NN transcription))
          (PP (IN of)
            (NP
              (NP (DT both) (NNS cytokines))
              (ADJP (JJ relative)
                (PP (TO to)
                  (NP (DT all) (JJ other) (NNS genotypes))))
              (, ,)
              (PP (VBG including)
                (NP (JJ Pax1-/-) (JJ single) (NNS mutants))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB However))
        (, ,)
        (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))
        (VP (VBD were) (RB not)
          (ADJP
            (ADJP (RB completely) (JJ missing))
            (CC either)
            (ADJP
              (NP (NN cytokine))
              (VBN analyzed)))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (DT the) (NN magnitude))
          (PP (IN of)
            (NP (DT the) (NN decrease))))
        (VP (VBD was)
          (ADJP (JJ variable))
          (PP (IN between)
            (NP (NNS pools))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB test)
            (SBAR (IN whether)
              (S
                (NP
                  (NP (DT the) (NNS changes))
                  (PP (IN in)
                    (NP (NN cytokine) (NNS levels))))
                (VP (VBD were)
                  (ADJP (JJ responsible)
                    (PP (IN for)
                      (NP (DT the) (VBN observed)
                        (NP (NN thymocyte) (NN development))
                        (NNS phenotypes))))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD attempted)
        (S
          (VP (TO to)
            (VP (VB rescue)
              (NP (DT these) (NNS phenotypes))
              (PP (IN by)
                (NP
                  (NP (NN supplementation))
                  (PP (IN in)
                    (NP
                      (NP (JJ fetal) (JJ thymic) (NN organ) (NN culture))
                      (PRN (-LRB- -LRB-)
                        (NP (NN FTOC))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD E15.5) (JJ embryonic) (JJ thymic) (NNS lobes))
        (PP (IN from)
          (NP (JJ individual) (NNS embryos))))
      (VP (VBD were)
        (VP (VBN cultured)
          (ADVP (RB separately))
          (PP (IN in)
            (NP (NN FTOC)))
          (, ,)
          (PP
            (PP (IN with))
            (CC or)
            (PP (IN without)
              (NP (VBN added)
                (NP (NN IL-7))
                (CC or)
                (NP (NN SCF))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Cultures))
      (PP (IN from)
        (NP
          (NP (JJ control) (NNS genotypes))
          (PRN (-LRB- -LRB-)
            (NP (JJ wild) (NN type))
            (, ,)
            (ADJP
              (ADJP (JJ Pax1+/-))
              (, ,)
              (ADJP (JJ Hoxa3+/-))
              (, ,)
              (ADJP (JJ Pax1-/-)))
            (-RRB- -RRB-)))))
    (VP (VBD behaved)
      (SBAR (IN as)
        (S
          (VP (VBN expected)
            (NP (CD -LSB-41-46) (-RRB- -RSB-))
            (, ,)
            (PP (IN with)
              (NP
                (NP (NN addition))
                (PP (IN of)
                  (NP
                    (NP (NN IL-7))
                    (VP (VBG causing)
                      (NP
                        (NP
                          (NP (DT an) (NN increase))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN percentage))
                              (PP (IN of)
                                (NP (JJ DN) (NNS cells))))))
                        (CC and)
                        (NP
                          (NP (DT a) (JJ corresponding) (NN decrease))
                          (PP (IN in)
                            (NP (NN DP) (NNS cells)))))))))))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (VBG adding) (NN SCF))
          (VP (VBD had)
            (NP (DT no) (JJ significant) (NN effect))
            (PP (IN on)
              (NP (NN thymocyte) (NN development)))
            (PRN (-LRB- -LRB-)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (TO to)
        (NP (PRP$ our) (NN surprise)))
      (NP
        (NP (DT the) (CD two) (JJ separated) (NNS lobes))
        (PP (IN from)
          (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))))
      (VP (VBD did) (RB not)
        (ADVP (RB always))
        (VP (VB develop)
          (PP (IN in)
            (NP (JJ predictable) (NNS ways))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN fact)))
      (, ,)
      (NP
        (NP (JJ separated) (NNS lobes))
        (VP (VBN cultured)
          (PP (IN under)
            (NP (JJ identical) (NNS conditions)))
          (PP (IN in)
            (NP
              (NP (DT the) (NN absence))
              (PP (IN of)
                (NP (DT any) (VBN added) (NNS cytokines)))))))
      (VP (VBD had)
        (NP
          (ADJP (RB widely) (VBG differing))
          (NNS results))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Changes))
        (PP (IN in)
          (NP
            (NP (NN thymocyte) (NN cell) (NN number))
            (CC and)
            (NP (NN differentiation))))
        (PP (IN after)
          (NP (NN culture))))
      (VP (VBD were)
        (ADJP (RB highly) (JJ variable))))
    (: ;)
    (S
      (PP (IN for)
        (NP (NN example)))
      (, ,)
      (NP (NN cell) (NNS numbers))
      (VP (MD could)
        (VP (VB differ)
          (ADVP (RB stochastically))
          (PP (IN after)
            (NP (NN culture)))
          (PP (IN by)
            (NP
              (NP (RB as) (JJ much))
              (PP (IN as)
                (NP
                  (NP (RB 10-fold))
                  (PP (IN between)
                    (NP
                      (NP (CD two) (NNS lobes))
                      (PP (IN from)
                        (NP (DT the) (JJ same) (NN compound) (JJ mutant) (NN embryo))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN result))
      (VP (VBD was)
        (ADVP (RB never))
        (VP (VBN obtained)
          (PP (IN with)
            (NP (RB separately) (VBN cultured) (JJ thymic) (NNS lobes)))
          (PP (IN from)
            (NP
              (NP (DT any) (JJ other) (NN genotype))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (ADVP (RB always))
                  (VP (VBD developed)
                    (ADVP (RB identically))
                    (SBAR
                      (WHADVP (WRB when))
                      (S
                        (VP (VBN cultured)
                          (PP (IN without)
                            (NP (NNS cytokines))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (NN property))
        (PP (IN of)
          (NP (DT the) (JJ compound) (JJ mutant) (JJ thymic) (NNS lobes))))
      (ADVP (RB probably))
      (VP (VBZ reflects)
        (NP
          (NP (JJ phenotypic) (NN variability))
          (VP
            (ADVP (RB previously))
            (VBN seen)
            (PP (IN in)
              (NP
                (NP (PRP$ our)
                  (ADJP
                    (ADJP (JJ histological))
                    (CC and)
                    (ADJP (JJ gross)))
                  (JJ morphological) (NN analysis))
                (PP (IN of)
                  (NP (DT these) (NNS mutants)
                    (NP (CD -LSB-29,34) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN study)))
      (, ,)
      (NP (PRP we))
      (VP (VBP have)
        (VP (VBN examined)
          (NP (NN thymocyte) (NN proliferation))
          (PP (IN in)
            (NP (DT the) (JJ fetal)
              (CC and)
              (JJ adult) (JJ wild) (NN type) (NN thymus))))))
    (. .)))

(
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (JJ clear) (JJ stage-specific) (NNS differences))
        (PP (IN in)
          (NP (JJ wild) (NN type) (NN thymocyte) (NN proliferation))))
      (PP (VBG depending)
        (PP (IN on)
          (NP
            (NP (DT the) (JJ developmental) (NN age))
            (PP (IN of)
              (NP (DT the) (NN microenvironment))))))
      (-LRB- -LRB-)
      (PP (FW i.e.)))))

(
  (S
    (NP
      (NP
        (ADJP (JJ fetal)))
      (CC vs.)
      (NP
        (ADJP (JJ adult))))
    (-RRB- -RRB-) (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD analyzed)
        (NP
          (NP (CD two) (JJ mutant) (NNS strains))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP have)
                (NP (DT either) (JJ cell-autonomous) (-LRB- -LRB-) (JJ Hoxa3+/-Pax1-/-) (-RRB- -RRB-)
                  (CC or)
                  (JJ non-cell-autonomous) (-LRB- -LRB-) (JJ Rag1-/-) (-RRB- -RRB-) (NN TEC) (NNS defects))
                (, ,)
                (PP (IN with)
                  (NP
                    (NP (NNS blocks))
                    (PP (IN at)
                      (NP
                        (NP (JJ different) (NNS stages))
                        (PP (IN of)
                          (NP (NN thymocyte) (NN differentiation)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Abnormal) (NN TEC) (NN development))
        (PP (IN in)
          (NP
            (NP (DT both))
            (PP (IN of)
              (NP (DT these) (JJ mutant) (NNS strains))))))
      (VP (VBD resulted)
        (PP (IN in)
          (NP
            (NP (CC both)
              (NP (NNS increases))
              (CC and)
              (NP (NNS decreases)))
            (PP (IN in)
              (NP (NN thymocyte) (NN proliferation)))
            (PP
              (PP (IN in)
                (NP (DT a) (JJ stage-specific) (NN manner)))
              (, ,)
              (CONJP (RB rather) (IN than))
              (ADVP (RB simply))
              (NP
                (NP (DT an)
                  (ADJP (RB overall) (VBN reduced))
                  (NN ability))
                (S
                  (VP (TO to)
                    (VP (VB promote)
                      (NP (NN proliferation)))))))))))
    (. .)))

(
  (S
    (S
      (NP (EX There))
      (VP (VBZ is)
        (NP (JJ considerable) (NN evidence)
          (SBAR (IN that)
            (S
              (NP (NN thymopoiesis))
              (VP (VBZ differs)
                (PP (IN in)
                  (NP
                    (NP (DT the) (JJ fetal) (NN thymus))
                    (PP (IN during)
                      (NP
                        (NP (DT the) (JJ initial) (NN creation))
                        (PP (IN of)
                          (NP (DT the) (NN microenvironment)))))))
                (, ,)
                (SBAR (IN as)
                  (S
                    (VP (VBN opposed)
                      (PP (TO to)
                        (NP
                          (NP (JJ adult) (NN thymus) (NN function))
                          (PRN (-LRB- -LRB-)
                            (VP (VBN reviewed)
                              (PP (IN in)
                                (NP (NN -LSB-47))))
                            (-RRB- -RSB-) (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Differences))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN reported)
            (PP
              (PP (IN in)
                (NP
                  (NP (NNS responses))
                  (PP (TO to)
                    (NP (DT some) (NNS cytokines)))))
              (, ,)
              (PP (IN in)
                (NP
                  (NP (NN signaling))
                  (PP (IN at)
                    (NP
                      (NP (DT the) (NN TN-DP) (NN transition))
                      (PP (IN in)
                        (NP (JJ fetal)))
                      (PP (VBN compared)
                        (PP (TO to)
                          (NP (JJ adult) (NN thymus))))))))
              (, ,)
              (CC and)
              (PP (IN in)
                (NP
                  (NP (NN proliferation))
                  (PP (IN of)
                    (NP (JJ CD4+) (NN SP) (NNS thymocytes)
                      (NP (CD -LSB-36,48-50))
                      (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN proliferation) (NNS profiles))
        (PP (IN of)
          (NP (CC both)
            (NP (JJ wild) (NN type))
            (CC and)
            (NP (JJ Rag-/-) (JJ fetal) (NNS thymocytes)))))
      (VP (VBP support)
        (NP (DT the) (NN hypothesis)
          (SBAR (IN that)
            (S
              (NP (JJ fetal) (NN thymocyte) (NN maturation))
              (VP (VBZ is)
                (ADJP (RB fundamentally) (JJ different)
                  (PP (IN from)
                    (NP
                      (NP (NN thymocyte) (NN development))
                      (PP (IN in)
                        (NP (DT the) (JJ adult) (NN thymus))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The)
        (NP
          (NP (NN TN1))
          (CC and)
          (NP (NN DP)))
        (NNS stages))
      (VP (DT both)
        (VP (VBP show)
          (NP
            (NP (VBN increased) (NN proliferation))
            (PP (IN in)
              (NP (JJ wild-type) (JJ fetal) (NNS thymocytes))))
          (PP (VBN compared)
            (PP (TO to)
              (NP (NNS adults)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (NN difference))
        (PP (IN at)
          (NP (DT the) (NN TN1) (NN stage))))
      (VP (VBZ is) (RB not)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (RBR more) (NN B)
                  (CC or)
                  (NN NK) (NNS cells)))
              (PP (IN in)
                (NP (DT the) (JJ adult) (NN thymus))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP (PRP it))
          (VP (VBZ is)
            (ADVP (RB formally))
            (ADJP (JJ possible))
            (SBAR (IN that)
              (S
                (NP (DT some) (JJ other) (NN cell) (NN type))
                (VP (MD may)
                  (ADVP (RB still))
                  (VP (VB be)
                    (VP (VBN included)
                      (PP (IN in)
                        (NP (PRP$ our) (NN TN1) (NN population)))))))))))
      (, ,)
      (NP (DT this) (NN analysis))
      (ADVP (RB strongly))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (NN TN1) (NNS cells))
            (VP (VBP have)
              (NP (JJ different) (NN proliferation) (NNS profiles))
              (PP (IN in)
                (NP
                  (ADJP
                    (ADJP (JJ fetal))
                    (CC and)
                    (ADJP (JJ adult)))
                  (NN thymus))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ has)
        (VP (VBN been)
          (ADVP (RB well))
          (VP (VBN documented)
            (SBAR (IN that)
              (S
                (NP
                  (NP (NNS thymocytes))
                  (PP (IN in)
                    (NP (JJ adult)
                      (NP
                        (NP (NN Rag1))
                        (CC or)
                        (NP (NN Rag2)))
                      (NNS mutants))))
                (VP (VBP have)
                  (NP
                    (ADJP (RB dramatically) (VBN reduced))
                    (NN proliferation))
                  (PP (VBN compared)
                    (PP (TO to)
                      (NP (JJ wild) (NN type))))
                  (, ,)
                  (PP
                    (ADVP (RB particularly))
                    (IN at)
                    (NP (DT the) (NN TN3) (NN stage) (CD -LSB-37-40) (-RRB- -RSB-))))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP Penit) (FW et) (FW al.))
      (VP (VBD reported)
        (NP (CD 2–10) (JJ fold) (NNS reductions))
        (PP (IN at)
          (NP
            (NP (DT every) (NN stage))
            (PP (IN of)
              (NP (NN thymocyte) (NN development)))))
        (PP (IN in)
          (NP (JJ Rag-/-) (NNS adults)))
        (NP (CD -LSB-13))
        (-RRB- -RSB-)))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Recent) (NN work))
        (PP (IN by)
          (NP
            (NP (NNP Petrie))
            (, ,)
            (ADVP (FW et) (FW al.)))))
      (VP (VBZ has)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (DT this) (VBN reduced) (NN proliferation))
              (VP
                (VP (VBZ is) (RB not)
                  (ADJP (JJ intrinsic)
                    (PP (TO to)
                      (NP (NN Rag) (JJ mutant) (NNS thymocytes)))))
                (, ,)
                (CONJP (CC but)
                  (RB rather))
                (VP (VBZ is)
                  (ADJP (JJ secondary)
                    (PP (TO to)
                      (NP
                        (NP (JJ thymic) (NN microenvironment) (NNS defects))
                        (PP (IN in)
                          (NP (NN Rag) (NNS mutants) (CD -LSB-37) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP (JJ fetal) (NNS stages)))
          (, ,)
          (NP (NN Rag) (NN mutant) (NNS thymocytes))
          (VP (VBP have)
            (NP
              (NP (DT a) (NN proliferation) (NN profile))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBZ is)
                    (ADJP
                      (ADVP (RB much) (RBR more))
                      (JJ similar)
                      (PP (TO to)
                        (NP
                          (NP
                            (NP (JJ wild) (NN type))
                            (NNS thymocytes))
                          (PP (IN at)
                            (NP (DT the) (JJ same) (NN stage))))))))))
            (, ,)
            (PP (IN with)
              (NP
                (ADJP (JJR less)
                  (PP (IN than)
                    (NP
                      (NP (DT a) (JJ 2-fold) (NN difference))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN percentage))
                          (PP (IN of)
                            (NP (VBG proliferating) (NNS cells)))
                          (PP (IN at)
                            (NP (DT any) (NN stage))))))))))))))
    (. .)))

(
  (S
    (PP (IN For)
      (NP (NN example)))
    (, ,)
    (NP
      (NP (NN TN3) (NN stage) (NNS thymocytes))
      (PP (IN in)
        (NP (DT the) (JJ Rag-/-) (JJ adult) (NN thymus))))
    (VP (VBP have)
      (NP
        (NP (NN proliferation) (NNS levels))
        (ADJP (JJ 3-fold)
          (PP (IN below)
            (NP (JJ wild) (NN type) (NN thymus) (NN -LSB-13,37))))
        (-RRB- -RSB-))
      (, ,)
      (SBAR (IN while)
        (S
          (PP (IN in)
            (NP (DT the) (JJ Rag-/-) (JJ fetal) (NN thymus)))
          (NP (NN TN3) (NNS cells))
          (VP (VBP are)
            (ADJP
              (NP
                (QP (RB only) (CD 25–30))
                (NN %))
              (JJR lower)
              (PP (IN than)
                (PP (IN in)
                  (NP (JJ wild) (NN type) (JJ fetal) (NN thymus)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Proliferation))
      (VP
        (VP (VBZ is) (RB not)
          (VP (VBN changed)
            (PP (IN at)
              (NP (DT all) (NNS stages)))))
        (, ,)
        (CC and)
        (VP (VBZ is)
          (ADVP (RB actually))
          (VP (VBN increased)
            (PP (JJ relative) (TO to)
              (NP (JJ wild) (NN type)))
            (PP (IN at)
              (NP (DT the) (JJ TN2) (NN stage)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (NN increase))
        (PP (IN at)
          (NP (DT the) (NN TN2) (NN stage))))
      (VP (MD may)
        (VP (VB be)
          (ADJP (JJ due)
            (PP (TO to)
              (NP
                (NP (DT the) (NN failure))
                (PP (IN of)
                  (NP (NN TN2) (NNS cells)))
                (S
                  (VP (TO to)
                    (VP (VB initiate)
                      (NP (NN TCRβ) (NN gene) (NN rearrangement))
                      (PP (IN at)
                        (NP
                          (NP (DT this) (NN stage))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (VBZ is)
                                (ADVP (RB normally))
                                (VP (VBN associated)
                                  (PP (IN with)
                                    (NP
                                      (NP (VBN decreased) (JJ proliferation.Rag-/-) (NNS mutants))
                                      (VP (VBP have)
                                        (NP (DT a) (JJ profound) (NN thymocyte) (NN development) (NN block))
                                        (PP (IN at)
                                          (NP (DT the) (NN TN3) (TO to) (NN TN4/preDP) (NN transition) (CD -LSB-51) (-RRB- -RSB-)))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN During)
        (NP (JJ normal) (JJ wild) (NN type) (JJ fetal) (NN thymus) (NN development)))
      (, ,)
      (NP (JJ significant) (NN DP) (NN cell) (NN development))
      (VP (VBZ does) (RB not)
        (VP (VB occur)
          (PP (IN until)
            (NP (NN E16.5)))
          (PP (IN in)
            (NP (JJS most) (JJ genetic) (NNS backgrounds))))))
    (. .)))

(
  (S
    (PP (IN As)
      (NP (DT a) (NN result)))
    (, ,)
    (PP (IN at)
      (NP (NN E17.5)))
    (NP
      (NP (DT the) (JJ thymic) (NN microenvironment))
      (PP (IN in)
        (NP (NN Rag) (NNS mutants))))
    (VP
      (VP (VBZ has) (RB not)
        (VP (VBN been)
          (VP (VBN exposed)
            (PP (TO to)
              (NP (JJ abnormal) (NN thymocyte) (NN development)))
            (PP (IN for)
              (ADJP (RB very) (JJ long))))))
      (, ,)
      (CC and)
      (VP (VBZ has) (RB not)
        (ADVP (RB yet))
        (VP (VBN developed)
          (NP
            (NP (DT the) (JJ full) (NN phenotype))
            (VP (VBN seen)
              (PP (IN in)
                (NP (DT the) (JJ steady) (NN state) (JJ adult) (NN Rag) (JJ mutant) (NN thymus) (CD -LSB-35))))))))
    (-RRB- -RSB-) (. .)))

(
  (S
    (PP (IN In)
      (NP (DT the) (NN Hoxa3)))
    (, ,)
    (NP (NN Pax1) (JJ compound) (NNS mutants))
    (, ,)
    (NP (JJ cell-autonomous) (NN TEC) (NNS defects))
    (VP (VBP cause)
      (NP
        (NP (DT a) (JJ partial) (NN block))
        (PP (IN at)
          (NP (DT the) (NN DN-DP) (NN transition))))
      (, ,)
      (SBAR (IN so)
        (S
          (NP (NNS thymocytes))
          (VP (VBP do)
            (VP (VB progress)
              (PP (TO to)
                (NP
                  (NP (NN DP))
                  (CC and)
                  (NP (NN SP) (NNS stages))))))))
      (, ,)
      (PP (IN albeit)
        (PP (IN at)
          (NP (VBD reduced) (NNS frequencies) (CD -LSB-29) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN TEC) (NNS defects))
      (VP (VBP are)
        (VP (VBN seen)
          (ADVP (RB as) (RB early))
          (PP (IN as)
            (NP
              (NP (NN E12.5))
              (PP (IN in)
                (NP (DT these) (NNS mutants)))))
          (, ,)
          (PP (IN from)
            (NP
              (NP (DT the) (JJS earliest) (NNS stages))
              (PP (IN of)
                (NP (NN organogenesis) (CD -LSB-34)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (DT the) (NN TEC) (NNS defects))
        (PP (IN in)
          (NP (DT these) (NNS mice))))
      (VP (MD would)
        (VP (VB be)
          (VP (VBN expected)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ different) (NNS effects))
                  (PP (IN on)
                    (NP (NN thymocyte) (NN proliferation)))
                  (PP (IN than)
                    (PP (IN in)
                      (NP (NN Rag) (NNS mutants)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN study)))
      (, ,)
      (NP (PRP we))
      (VP (VBD found)
        (NP
          (NP (JJ stage-specific) (NNS changes))
          (PP (IN in)
            (NP (NN thymocyte) (NN proliferation))))
        (PP (IN at)
          (NP (DT the) (NN DP) (NN stage)))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (JJ previous) (NN analysis))
      (VP (VBD reported)
        (NP
          (NP (VBN decreased) (NN DP) (NN cell) (NN number))
          (CC and)
          (NP
            (NP (VBN increased) (NN apoptosis))
            (PP (IN in)
              (NP
                (NP (CC both)
                  (DT the)
                  (NP
                    (NP (NN pre-DP))
                    (CC and)
                    (NP (NN DP)))
                  (NNS stages))
                (PP (IN in)
                  (NP (DT these) (NNS mutants)
                    (NP (CD -LSB-29) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN DP) (NN cell) (NNS numbers))
        (PP (IN in)
          (NP (CC both)
            (DT this)
            (CC and)
            (PRP$ our) (JJ previous) (NN study))))
      (VP (VBD were)
        (VP (VBN decreased)
          (ADVP (RB 10-fold))
          (PP (IN in)
            (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP (JJ first) (NN glance)))
      (, ,)
      (NP
        (NP (DT the) (NN increase))
        (PP (IN in)
          (NP
            (NP (DT the) (NN percentage))
            (PP (IN of)
              (NP (VBG proliferating) (NNS cells)))))
        (PP (IN at)
          (NP (DT the) (NN DP) (NN stage))))
      (VP (VBZ appears)
        (ADJP (JJ contradictory)
          (PP (TO to)
            (NP (DT this) (NN phenotype))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (DT this) (NN increase))
      (ADVP (RB actually))
      (VP (VBZ corresponds)
        (PP (TO to)
          (NP
            (NP (VBN decreased) (NNS numbers))
            (PP (IN of)
              (NP (VBG proliferating) (NN DP) (NNS cells)))))
        (PP (VBN compared)
          (PP (TO to)
            (NP (JJ wild) (NN type))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (NN pre-DP) (NNS cells))
      (VP (VBD did) (RB not)
        (VP (VB have)
          (NP
            (NP (DT a) (NN change))
            (PP (IN in)
              (NP
                (NP (DT the)
                  (NP (NN number))
                  (CC or)
                  (NP (NN percentage)))
                (PP (IN of)
                  (NP (VBG proliferating) (NNS cells)))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (SBAR
              (SBAR (IN that)
                (S
                  (NP
                    (NP (DT the) (NNS signals) (VBG promoting) (NN proliferation))
                    (PP (IN of)
                      (NP (DT these) (NNS cells))))
                  (VP (VBZ is)
                    (ADVP (RB still))
                    (ADJP (JJ present)))))
              (, ,)
              (CC and)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (NN proliferation))
                    (PP (IN of)
                      (NP (NN DP)
                        (CC and)
                        (NN pre-DP) (NNS cells))))
                  (VP (MD may)
                    (VP (VB be)
                      (VP (VBN regulated)
                        (ADVP (RB independently))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Pre-DP) (NNS cells))
      (VP (VBP do)
        (VP (VB have)
          (NP
            (NP (DT a) (JJ three-fold) (NN increase))
            (PP (IN in)
              (NP (NN apoptosis) (CD -LSB-29) (-RRB- -RSB-))))
          (, ,)
          (S
            (VP (VBG suggesting)
              (SBAR (IN that)
                (S
                  (NP (JJ separate) (NNS signals))
                  (VP (VBP regulate)
                    (NP
                      (NP
                        (NP (NN proliferation))
                        (CC and)
                        (NP (NN survival)))
                      (PP (IN of)
                        (NP (DT these) (NNS cells))))))))))))
    (. .)))

(
  (S
    (S
      (ADJP (JJ Combined)
        (PP (IN with)
          (NP (PRP$ our) (JJ previous) (NNS data)))))
    (, ,)
    (NP (DT this) (NN result))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN decrease))
            (PP (IN in)
              (NP (NN DP) (NN cell) (NNS numbers)))
            (VP (VBN seen)
              (PP (IN in)
                (NP (DT the) (NN Hoxa3-Pax1) (NN compound) (NNS mutants)))))
          (VP (VBZ is)
            (PP (CC both)
              (JJ due) (TO to)
              (NP
                (NP
                  (NP (DT an) (NN increase))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN number))
                      (PP (IN of)
                        (NP
                          (NP (NN pre-DP)
                            (CC and)
                            (NN DP) (NNS cells))
                          (VP (VBG undergoing)
                            (NP (NN apoptosis))))))))
                (CONJP (RB as) (RB well) (IN as))
                (NP
                  (NP (DT a) (NN decrease))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN number))
                      (PP (IN of)
                        (NP (JJ proliferating) (NN DP))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Insufficiencies))
        (PP (IN of)
          (NP (JJ multiple) (NNS cytokines))))
      (VP (MD might)
        (VP (VB be)
          (VP (VBN involved)
            (PP (IN in)
              (NP
                (NP (DT the) (NNS changes))
                (PP (IN in)
                  (NP
                    (NP (NN proliferation))
                    (CC and)
                    (NP
                      (NP (NN cell) (NN death))
                      (PP (IN at)
                        (NP (DT the) (NN CD44-25-)
                          (CC and)
                          (NN DP) (NNS stages)))
                      (PP (IN in)
                        (NP (NN Hoxa3-Pax1) (NN compound) (NNS mutants))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN SCF))
        (CC and)
        (NP (NN IL-7)))
      (VP (VBP are)
        (ADVP (RB first))
        (VP (VBN expressed)
          (ADVP (RB as) (RB early))
          (PP (IN as)
            (NP
              (NP (NN E12.5))
              (PP (IN in)
                (NP (DT the) (VBG developing) (NN thymus)))))
          (, ,)
          (SBAR (RB well) (IN before)
            (S
              (NP (JJ significant) (NN thymocyte) (NN maturation))
              (VP (VBZ takes)
                (NP (NN place) (CD -LSB-52,53) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP
            (NP (DT the) (NN number))
            (PP (IN of)
              (NP (NNS TECs))))
          (VP (VBZ is)
            (VP (VBN reduced)
              (PP (IN by)
                (NP (RB about) (RB 2-fold)))
              (PP (IN in)
                (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)))))))
      (, ,)
      (NP
        (NP (DT the) (NN number))
        (PP (IN of)
          (NP (NNS thymocytes))))
      (VP (VBZ is)
        (VP (VBN reduced)
          (PP (IN by)
            (NP
              (NP (DT a)
                (ADJP (RB slightly) (JJR greater))
                (NN amount))
              (PRN (, ,)
                (PP (IN around)
                  (NP (RB 3-fold) (CD -LSB-29)))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (DT the) (NNS reductions))
        (VP (VBN seen)
          (PP (IN in)
            (NP
              (NP (NN cytokine) (NN message) (NNS levels))
              (PP (IN in)
                (NP (DT the) (JJ Hoxa3+/-Pax1-/-compound) (NNS mutants)))))))
      (VP (VBP are) (RB not)
        (ADJP (JJ secondary)
          (PP (TO to)
            (NP (VBN decreased) (NN TEC) (NNS numbers))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN fact)))
    (, ,)
    (NP (DT these) (NNS mutants))
    (VP (MD should)
      (VP (VB have)
        (NP
          (NP (DT a) (JJ relative) (NN increase))
          (PP (IN in)
            (NP
              (NP (DT the) (NN proportion))
              (PP (IN of)
                (NP (NNS TECs))))))
        (, ,)
        (S
          (VP (VBG making)
            (NP
              (NP (DT the) (NNS reductions))
              (VP (VBN seen)
                (PP (IN in)
                  (NP (NN cytokine) (NNS levels)))
                (PP (IN in)
                  (NP
                    (NP (DT the) (JJ mutant) (NN thymi))
                    (ADJP
                      (ADVP (RB even) (RBR more))
                      (JJ striking))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (VBN reduced) (NN expression))
        (PP (IN of)
          (NP (DT these) (NNS cytokines)))
        (PP (IN in)
          (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))))
      (VP
        (VP (MD could)
          (VP (VB be)
            (NP
              (NP (DT an) (JJ indirect) (NN effect))
              (PP (IN of)
                (NP (JJ defective) (NN TEC) (NN differentiation))))))
        (, ,)
        (CC or)
        (VP (MD could)
          (VP (VB be)
            (NP (JJ direct) (JJ downstream) (NNS targets))
            (SBAR (IN since)
              (S
                (NP (CC both)
                  (NP (NN Hoxa3))
                  (CC and)
                  (NP (NN Pax1)))
                (VP (VBP are)
                  (VP (VBN expressed)
                    (PP (IN in)
                      (NP (JJ fetal) (NN thymus) (CD -LSB-54,55)))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Comparison))
        (PP (IN of)
          (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN phenotype)))
        (PP (IN with)
          (NP
            (NP (DT those))
            (PP (IN of)
              (NP (NN cytokine) (NNS mutants))))))
      (VP (VBP do) (RB not)
        (VP (VB reveal)
          (NP (JJ many) (NNS similarities) (CD -LSB-30,46,56-61) (-RRB- -RSB-))
          (, ,)
          (PP (RB probably) (IN because) (IN of)
            (NP
              (NP (DT the) (JJ simultaneous) (NNS reductions))
              (PP (IN in)
                (NP
                  (NP (JJ multiple) (NNS cytokines))
                  (PP (IN in)
                    (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NNS mutants))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN example)))
      (, ,)
      (NP
        (NP (NN SCF))
        (CC and)
        (NP (NN IL-7)))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ synergistic) (NNS functions) (CD -LSB-62,63) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (NNS changes))
        (PP (IN in)
          (NP (JJ multiple) (NNS cytokines)))
        (PP (IN in)
          (NP (JJ Hoxa3+/-Pax1-/-) (NNS mutants))))
      (VP (MD would)
        (VP (VB be)
          (VP (VBN expected)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP
                    (NP (JJ complex) (NNS effects))
                    (PP (IN on)
                      (NP (NN thymocyte) (NN development)))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (MD could)
                          (VP (VB be)
                            (ADJP (JJ difficult)
                              (S
                                (VP (TO to)
                                  (VP (VB predict)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Interpretation))
        (PP (IN of)
          (NP (DT the) (VBN observed) (NN phenotype))))
      (VP (VBZ is)
        (ADVP (RB further))
        (VP (VBN complicated)
          (PP (IN by)
            (NP (DT the) (NN fact)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (NN none))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NNS cytokines))
                        (VP (VBN tested)))))
                  (VP (VBP are)
                    (ADJP (RB completely) (JJ absent))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ striking) (NN example))
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJ complete) (NN absence))
          (PP (IN of)
            (NP (JJ γδTCR+) (NN thymocyte) (NN development)))
          (PP (IN in)
            (NP (NN IL-7) (NNS mutants))))
        (, ,)
        (PP (IN in) (NN contrast) (TO to)
          (NP
            (NP (JJ normal) (JJ γδTCR+) (NN cell) (NN development))
            (PP (IN in)
              (NP (JJ Hoxa3+/-Pax1-/-) (NNS mutants)
                (NP
                  (NP (CD -LSB-29) (-RRB- -RSB-))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP have)
                        (NP
                          (ADJP (RB dramatically) (VBN reduced))
                          (NN IL-7) (NNS levels))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN result))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (SBAR (IN although)
              (S
                (NP (JJ γδTCR+) (NN cell) (NN development))
                (VP (VBZ requires)
                  (NP (NN IL-7)))))
            (, ,)
            (NP (JJ low) (NNS levels))
            (VP (VBP are)
              (ADJP (JJ sufficient)
                (PP (IN for)
                  (NP (DT this) (NN function)))))))))
    (. .)))

(
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (NN analysis))
      (PP (IN of)
        (NP
          (NP (NNS mutants))
          (PP (IN with)
            (NP
              (NP (JJ low) (NNS levels))
              (PP (IN of)
                (NP (NNS cytokines))))))))
    (VP (MD may)
      (VP (VB provide)
        (NP
          (NP (DT a) (NN system))
          (PP (IN for)
            (S
              (VP (VBG uncovering)
                (NP
                  (NP (CC both)
                    (NP (JJ dosage-dependent) (NNS requirements))
                    (CC and)
                    (NP (JJ later) (NNS functions)))
                  (PP (IN for)
                    (NP (DT these) (NNS factors))))
                (PP (IN in)
                  (S
                    (VP (VBG promoting)
                      (NP (NN thymocyte) (NN development)))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADVP (RB also))
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT some))
              (PP (IN of)
                (NP
                  (NP (DT the) (NNS differences))
                  (VP (VBN seen)
                    (PP (IN between)
                      (NP
                        (ADJP
                          (ADJP (JJ Hoxa3+/-Pax1-/-))
                          (CC and)
                          (ADJP (NN cytokine) (JJ mutant)))
                        (NNS phenotypes)))))))
            (VP (VBP reflect)
              (NP
                (NP (JJ different) (NNS effects))
                (PP (IN of)
                  (NP (NNS cytokines))))
              (PP (IN at)
                (NP
                  (ADJP
                    (ADJP (JJ fetal))
                    (CC and)
                    (ADJP (JJ adult)))
                  (NNS stages))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Studies))
        (PP (IN of)
          (NP (NN IL-7R) (NNS mutants))))
      (VP (VBD showed)
        (NP
          (ADJP (RB relatively) (JJ normal))
          (NN thymocyte) (NN maturation))
        (PP (IN at)
          (NP (JJ fetal) (NNS stages)))
        (, ,)
        (PP (IN albeit)
          (PP (IN with)
            (NP (VBN reduced) (NN thymocyte) (NNS numbers))))
        (, ,)
        (PP (IN in) (NN contrast) (TO to)
          (NP
            (NP (DT a) (JJ severe) (NN block))
            (PP (IN in)
              (NP (NN thymocyte) (NN differentiation)))
            (PP (IN in)
              (NP (JJ adult) (NN thymus) (CD -LSB-49))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Analysis))
        (PP (IN of)
          (NP (NN cytokine) (NNS mutants)))
        (PP (IN during)
          (NP (JJ fetal) (NNS stages))))
      (VP (MD could)
        (ADVP (RB therefore))
        (VP (VBP reveal)
          (NP
            (NP (DT a)
              (ADJP (RBR more) (JJ complete))
              (NN picture))
            (PP (IN of)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (DT these) (NNS cytokines)))
                (PP (IN during)
                  (NP (JJ fetal) (NN thymus) (NN development)))))))))
    (. .)))

(
  (S
    (NP (NNS Conclusions))))

(
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP
            (ADJP
              (ADJP (JJ fetal))
              (CC and)
              (ADJP (JJ adult)))
            (JJ wild) (NN type) (NNS thymocytes))
          (VP (VBP have)
            (NP
              (NP (JJ stage-specific) (NNS differences))
              (PP (IN in)
                (NP (NN proliferation))))
            (, ,)
            (PP (IN with)
              (NP (CC both)
                (NP (NN TN1))
                (CC and)
                (NP
                  (NP (NN DP) (NNS cells))
                  (VP (VBG exhibiting)
                    (NP
                      (NP (JJR higher) (NNS levels))
                      (PP (IN of)
                        (NP (NN proliferation))))
                    (PP (IN in)
                      (NP (JJ fetal) (NN thymus)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (JJ fetal) (JJ wild-type) (NN profile))
      (VP (VBD was)
        (ADJP (RB very) (JJ similar)
          (PP (TO to)
            (NP
              (NP (DT that))
              (VP (VBN seen)
                (PP (IN for)
                  (NP (JJ fetal) (NN Rag) (JJ mutant) (NNS thymocytes)))))))
        (, ,)
        (PP (IN in) (NN contrast) (TO to)
          (NP (JJ adult) (JJ Rag-/-) (NN thymus)))))
    (. .)))

(
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (DT the) (NNS changes))
      (PP (IN in)
        (NP
          (NP (NN proliferation))
          (VP (VBN seen)
            (PP (IN in)
              (NP (DT the) (JJ fetal) (NN Rag) (JJ mutant) (NNS thymocytes)))))))
    (VP (VBP reflect)
      (NP
        (NP (DT the) (JJS earliest) (NN microenvironment) (NNS changes))
        (VP (VBG occurring)
          (PP (IN as)
            (NP
              (NP (DT a) (NN result))
              (PP (IN of)
                (NP
                  (NP (JJ defective) (JJ TEC-thymocyte) (NNS interactions))
                  (PP (IN in)
                    (NP (DT the) (JJ Rag-/-) (NN thymus))))))))))
    (. .)))

(
  (S
    (NP (DT The) (JJ current) (NN study))
    (ADVP (RB further))
    (VP
      (VP (VBZ supports)
        (NP
          (NP (DT a) (NN role))
          (PP (IN for)
            (NP (NNS TECs)))
          (PP (IN in)
            (S
              (VP (VBG regulating)
                (NP (CC both)
                  (NP (NN thymocyte) (NN proliferation))
                  (CC and)
                  (NP (NN survival)))
                (PP (IN during)
                  (NP (DT the) (NN DN-DP) (NN transition))))))))
      (, ,)
      (CC and)
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (NN proliferation))
                (CC and)
                (NP (NN apoptosis)))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN TN4))
                    (CC and)
                    (NP (NN DP)))
                  (NNS cells))))
            (VP (VBP are)
              (VP (VBN regulated)
                (ADVP (RB independently))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBP provide)
        (NP
          (NP (JJ direct) (JJ genetic) (NN evidence))
          (PP (IN for)
            (NP
              (NP (DT these) (NNS functions))
              (PP (IN of)
                (NP (NNS TECs))))))
        (, ,)
        (PP (IN by)
          (S
            (VP (VBG showing)
              (SBAR (IN that)
                (S
                  (NP (DT these) (NNS processes))
                  (VP (VBP are)
                    (ADJP (JJ defective)
                      (PP (IN in)
                        (NP
                          (NP (NNS mutants))
                          (PP (IN with)
                            (NP
                              (NP (DT a) (JJ primary) (NN TEC) (NN differentiation) (NN defect))
                              (PRN (-LRB- -LRB-)
                                (NP
                                  (NP (DT the) (NN Hoxa3))
                                  (, ,)
                                  (NP (NN Pax1) (NN compound) (NNS mutants)))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))))
      (, ,)
      (NP (PRP$ our) (NNS results))
      (ADVP (RB further))
      (VP (VBP define)
        (NP (DT the) (NN role)
          (S
            (NP (NNS TECs))
            (VP (VBP play)
              (PP (IN at)
                (NP
                  (NP (DT this) (JJ complex) (NN stage))
                  (PP (IN of)
                    (NP (NN thymocyte) (NN development))))))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (S
      (NP (JJ Hoxa3+/-Pax1+/-) (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN mated)
            (PP (TO to)
              (NP
                (ADJP
                  (ADJP (JJ Pax1+/-))
                  (CC or)
                  (ADJP (JJ Pax1-/-)))
                (NNS mice))))
          (CC and)
          (VP (VBN genotyped)
            (PP (IN for)
              (NP (CC both)
                (NP (NN Hoxa3))
                (CC and)
                (NP (NN Pax1))))
            (PP (IN by)
              (NP (NN PCR)))
            (SBAR (IN as)
              (S
                (VP (VBN described)
                  (ADVP (RB previously))
                  (NP (CD -LSB-29) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Comparisons))
      (VP (VBD were)
        (VP (VBN made)
          (PP (IN between)
            (NP
              (NP (NNS littermates))
              (PP (IN from)
                (NP (DT the) (JJ same) (NN colony))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Rag1-/-) (NNS mice))
        (PRN (-LRB- -LRB-)
          (NP (NN Jackson) (NNS Labs))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN maintained)
          (PP (IN as)
            (NP (DT a) (JJ homozygous) (JJ mutant) (NN colony))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS mice))
      (VP (VBD were)
        (VP (VBN maintained)
          (PP (IN as)
            (NP (NN congenic)))
          (PP (IN on)
            (NP (DT a) (NN C57BL/6) (JJ genetic) (NN background))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Noon))
        (PP (IN of)
          (NP
            (NP (DT the) (NN day))
            (PP (IN of)
              (NP (JJ vaginal) (NN plug))))))
      (VP (VBD was)
        (VP (VBN considered)
          (NP (NN E0.5)))))
    (. .)))

(
  (S
    (NP (DT All) (NN animal) (NN use) (NNS procedures))
    (VP (VBD were)
      (ADJP (JJ approved)
        (PP (IN by)
          (NP
            (NP (DT the) (JJ Medical) (NN College))
            (PP (IN of)
              (NP (NNP Georgia) (NNP Committee))))))
      (PP (IN on)
        (NP
          (NP (JJ Animal) (NN Use))
          (PP (IN for)
            (NP
              (NP (NN Research))
              (CC and)
              (NP
                (NP (NN Education))
                (PRN (-LRB- -LRB-)
                  (NP (NN CAURE))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Fetal) (NN thymocyte)
        (ADJP (FW in) (FW vivo))
        (NN BrdU) (NN incorporation))
      (VP (VBD was)
        (VP (VBN done)
          (PP (IN by)
            (NP
              (NP (JJ intraperitoneal) (NN injection))
              (PP (IN of)
                (NP (NN BrdU)))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN 5-Bromo-2'-Deoxyuridine))
              (: ;)
              (NP (NN Sigma)))
            (-RRB- -RRB-))
          (PP (IN on) (DT the) (NN morning) (IN of)
            (NP
              (NP (NN E17.5))
              (, ,)
              (NP
                (NP (CD two) (NNS doses))
                (PP (IN per)
                  (NP (NN mouse))))
              (CC and)
              (NP
                (NP (CD 1) (NN mg))
                (PP (IN per)
                  (NP (NN dose))))))
          (PP (IN with)
            (NP
              (NP (DT a)
                (ADJP (CD 0.5) (NN hour))
                (NN pause))
              (PRN (, ,)
                (PP (IN as)
                  (NP
                    (ADJP (RB previously) (VBN described))
                    (NN -LSB-13)))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP
        (NP (CD Two) (NNS hours))
        (IN after)
        (NP (DT the) (JJ first) (NN injection)))
      (, ,)
      (NP (JJ fetal) (NNS thymi))
      (VP (VBD were)
        (VP (VBN isolated)
          (PP (IN by)
            (NP
              (NP (NN dissection))
              (CC and)
              (NP
                (NP (NN single-cell) (NNS suspensions))
                (VP (VBN prepared)
                  (PP (IN by)
                    (S
                      (VP (VBG passing)
                        (NP (DT the) (NNS thymocytes))
                        (PP (IN through)
                          (NP (NN cell) (NNS strainers)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Adult) (NN thymocyte)
        (ADJP (FW in) (FW vivo))
        (NN BrdU) (NN incorporation))
      (VP (VBD was)
        (VP (VBN done)
          (PP (IN by)
            (NP
              (NP (DT the) (JJ same) (NN injection) (NN protocol))
              (VP (VBG using)
                (NP
                  (ADJP (CD 6–8) (NN week) (JJ old))
                  (NN C57BL/6) (JJ adult) (NNS mice))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Four-color) (NN flow) (NN cytometry))
      (VP (VBD was)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the)
                  (NP
                    (NP (JJ following) (JJ monoclonal) (NNS antibodies))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Pharmingen))
                      (-RRB- -RRB-))))
                (: :)
                (NP
                  (NP
                    (NP (NN biotin) (JJ anti-mouse) (NN CD25))
                    (PRN (-LRB- -LRB-)
                      (NP (NN clone) (: :) (NN 7D4))
                      (-RRB- -RRB-)))
                  (VP (VBN visualized)
                    (PP (IN with)
                      (NP
                        (NP (NN Per-CP))
                        (VP (VBN conjugated)
                          (NP
                            (NP (NN streptavidin))
                            (: ;)
                            (NP
                              (NP (NN APC) (JJ anti-mouse) (NN CD44))
                              (PRN (-LRB- -LRB-)
                                (NP (NN clone))
                                (: :)
                                (NP (NN IM7))
                                (-RRB- -RRB-)))
                            (: ;)
                            (CC and)
                            (NP
                              (NP (CD three) (NN phycoerythrin))
                              (PRN (-LRB- -LRB-)
                                (NP (NN PE))
                                (-RRB- -RRB-)))
                            (NP (VBN conjugated) (NNS antibodies)))))))
                  (: :)
                  (NP
                    (NP (JJ anti-mouse) (NN CD4))
                    (PRN (-LRB- -LRB-)
                      (NP (NN clone) (: :) (CD RM4-5))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ anti-mouse) (NN CD8a))
                    (PRN (-LRB- -LRB-)
                      (NP (NN clone) (: :) (CD 53–6.7))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (JJ anti-mouse) (NN CD3ε))
                    (PRN (-LRB- -LRB-)
                      (NP (NN clone) (: :) (NN 145-2C11))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT some) (NNS experiments)))
      (, ,)
      (NP
        (NP (CD PE) (VBN conjugated) (NNS antibodies))
        (PP (IN against)
          (NP
            (NP
              (NP (NN B220))
              (PRN (-LRB- -LRB-)
                (NP (NN clone) (: :) (NN RA3-6B2))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (NN NK1.1))
              (PRN (-LRB- -LRB-)
                (NP (NN clone) (: :) (NN PK136))
                (-RRB- -RRB-))))))
      (VP (VBD were)
        (ADVP (RB also))
        (VP (VBN included))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP (NN cell) (NN surface) (NN staining)))
      (, ,)
      (NP (DT the) (NNS cells))
      (VP (VBD were)
        (NP
          (ADJP (JJ fixed)
            (PP (IN with)
              (NP
                (ADJP (CD 2) (NN %))
                (NN paraformaldehyde))))
          (PRN (-LRB- -LRB-)
            (NP (NN PFA))
            (-RRB- -RRB-))
          (NNS /PBS))
        (PP (IN at)
          (NP (JJ 4°C) (JJ overnight)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS cells))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN washed) (, ,)
          (VP (JJ permeabilized)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 0.1) (NN %))
                  (NN Triton) (NN X-100/) (CD 0.1) (NN %) (NN Na-Citrate) (-LRB- -LRB-) (CD pH7.2) (-RRB- -RRB-))
                (PP (IN on)
                  (NP (NN ice)))))
            (PP (IN for)
              (NP (CD 2) (NN min))))
          (, ,)
          (CC and)
          (ADVP (RB then))
          (VP (VBN treated)
            (PP (IN with)
              (NP
                (NP (CD 50) (NNS units))
                (PP (IN of)
                  (NP (NN DNaseI) (NN at) (NN 37°C)))))
            (PP (IN for)
              (NP (CD 10) (NN min)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NN FITC) (NN anti-BrdU) (NN antibody))
              (PRN (-LRB- -LRB-)
                (NP (NN Pharmingen))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Data))
        (VP (VBD were)
          (VP (VBN collected)
            (PP (IN by)
              (S
                (ADVP (RB selectively))
                (VP (VBG gating)
                  (NP
                    (NP
                      (ADJP (CC either)
                        (ADJP (JJ CD3-4-8-))
                        (CC or)
                        (ADJP (JJ CD3+4+8+)))
                      (NNS populations))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP Becton) (NNP Dickinson))
                        (NP (JJ dual) (NN laser) (NN FACSCalibur)))
                      (-RRB- -RRB-)))))))))
      (, ,)
      (CC and)
      (S
        (NP (NNS analyses))
        (VP (VBD were)
          (VP (VBN performed)
            (PP (IN with)
              (NP (NN Cellquest) (NN software)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Significant) (NNS differences))
      (VP (VBD were)
        (VP (VBN determined)
          (PP (IN by)
            (NP
              (NP
                (NP (DT the) (JJ unpaired) (NN Student) (POS 's))
                (NN t-test))
              (CC or)
              (NP (NN ANOVA) (NN analysis)))))))
    (. .)))

(
  (S
    (S
      (NP (NN E14.5) (JJ fetal) (JJ thymic) (NNS lobes))
      (VP (VBD were)
        (VP
          (VP (VBN collected))
          (CC and)
          (VP (VBN stored)
            (PP (IN in)
              (NP
                (NP (DT the) (NN TRIzol))
                (PRN (-LRB- -LRB-)
                  (NP (NN GIBCO) (NN BRL))
                  (-RRB- -RRB-))))
            (PP (IN at)
              (NP (NN -70°C)))
            (PP (IN until)
              (NP (NN RNA) (NN isolation)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Pools))
        (PP (IN of)
          (NP
            (NP (NN 5-to10) (NN thymi))
            (PP (IN from)
              (NP
                (NP (NNS embryos))
                (PP (IN of)
                  (NP (DT the) (JJ same) (NN genotype))))))))
      (VP (VBD were)
        (VP (VBN homogenized)
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP (NN Micro) (NN Pellet) (NNS Pestles))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Nalge) (NNP Nunc) (NNP International))
                    (-RRB- -RRB-)))
                (PP (IN in)
                  (NP
                    (ADJP (CD 1.5) (NN ml-eppendorf))
                    (NNS tubes)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN RNA))
        (VP (VBD was)
          (VP (VBN isolated))))
      (CC and)
      (S
        (NP (DT the) (JJ genomic) (NN DNA))
        (VP (VBD was)
          (VP (VBN depleted)
            (PP (IN by)
              (S
                (VP (VBG using)
                  (NP
                    (NP (NN DNaseI))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN Amplification) (NN Grade))
                        (, ,)
                        (NP (NN GIBCO) (NN BRL)))
                      (-RRB- -RRB-))))))
            (PP (VBG following)
              (NP
                (NP (DT the) (NN manufacturer) (POS 's))
                (NNS protocols)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Reverse) (NN transcription))
        (PP (IN of)
          (NP
            (NP (CD 1) (NN μg))
            (PP (IN of)
              (NP (JJ total) (NN RNA)))
            (PP (TO to)
              (NP (NN cDNA))))))
      (VP (VBD was)
        (VP (VBN done)
          (S
            (VP (VBG using)
              (NP
                (NP (NN SuperScript) (CD II))
                (VP (VBG following)
                  (NP
                    (NP
                      (NP (DT the) (NN manufacturer) (POS 's))
                      (NN protocol))
                    (PRN (-LRB- -LRB-)
                      (NP (NN GIBCO) (NN BRL))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Equal) (NNS amounts))
        (PP (IN of)
          (NP
            (NP (NN cDNA))
            (PP (IN from)
              (NP (JJ different) (NNS genotypes))))))
      (VP (VBD were)
        (VP (VBN added)
          (PP (TO to)
            (NP
              (NP (DT a) (JJ final) (CD 20) (NN μl) (NN PCR) (NN reaction) (NN mixture))
              (VP (VBG using)
                (NP (DT the) (NN QIAGEN) (NN Taq) (NN PCR) (NNS kits))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN PCR) (NNS conditions))
        (VP (VBD were)))
      (: :)
      (FRAG
        (NP (NN 94°C) (CD 30) (NN sec))
        (, ,)
        (NP
          (NP (NN 50°C) (CD 1) (NN min))
          (, ,)
          (NP
            (NP (NN 72°C) (CD 1) (NN min))
            (PP (IN for)
              (NP
                (NP (NN IL-7))
                (, ,)
                (NP (NN SCF))
                (CC and)
                (NP (PRP$ their) (JJ internal) (NN control) (NN β-actin)))))
          (: ;)
          (CC or)
          (NP (NN 94°C) (CD 30) (NN sec))
          (, ,)
          (NP (NN 60°C) (CD 1) (NN min))
          (, ,)
          (CC 72°C)
          (NP
            (NP (CD 1) (NN min))
            (PP (IN for)
              (NP
                (NP (NN TGFβ1))
                (CC and)
                (NP (PRP$ its) (JJ internal) (NN control) (NN β-actin))))))))
    (. .)))

(
  (S
    (S
      (NP (NN PCR) (NNS products))
      (VP (VBD were)
        (VP (VBN visualized)
          (PP (IN by)
            (NP
              (NP
                (ADJP (CD 5) (NN %))
                (NN acrylamide) (NN gel) (NN electrophoresis))
              (CC and)
              (NP
                (NP (NN ethidium) (NN bromide))
                (NN staining)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Band) (NNS densities))
      (VP (VBD were)
        (VP
          (VP (VBN measured))
          (CC and)
          (VP (VBN analyzed)))
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (JJ Molecular) (NN Analyst) (NN software) (NN package))
              (PRN (-LRB- -LRB-)
                (NP (JJ Bio-Rad) (NNS Laboratories))
                (, ,)
                (NP (NN Version) (CD 1.4.1))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Primer) (NNS sequences))
      (VP (VBD were) (: :)
        (NP
          (NP (NN IL-7) (CD -LSB-65) (-RRB- -RSB-))
          (: :)
          (NP
            (NP (NN IL-7)
              (PRN (-LRB- -LRB-)
                (NP (CD 5) ('' '))
                (-RRB- -RRB-))
              (CD 5))
            (VP (`` ') (VB ACT)
              (NP (NN ACA) (NN CCC) (NN ACC) (NN TCC) (NN CGC) (NN A3) (POS '))))
          (: ;)
          (NP
            (NP (NN IL-7)
              (PRN (-LRB- -LRB-)
                (NP (CD 3) ('' '))
                (-RRB- -RRB-))
              (CD 5))
            (NP (`` ') (JJ TCT) (NN CAG) (NN TAG) (NN TCT) (NN CTT) (NN TAG) (NN G3) ('' ')))
          (: ;)
          (NP (NN SCF) (CD -LSB-65) (-RRB- -RSB-))
          (: :)
          (NP
            (NP
              (NP (NN SCF))
              (PRN (-LRB- -LRB-)
                (NP (CD 5) ('' '))
                (-RRB- -RRB-)))
            (S
              (S
                (NP
                  (ADJP (CD 5) ('' ') (JJ TCT))
                  (NN TCA))
                (VP (VB ACT)
                  (NP (NN GCT) (NN CCT) (NN ATT) (NN T3) (POS '))))
              (: ;)
              (S
                (NP (NN SCF)
                  (PRN (-LRB- -LRB-)
                    (NP (CD 3) ('' '))
                    (-RRB- -RRB-))
                  (CD 5))
                (VP (`` ') (VB ACT)
                  (NP
                    (NP
                      (NP (NN GCT))
                      (VP (VB ACT)
                        (NP (NN GCT) (NN GTC) (NN ATT) (NN C3) (POS '))))
                    (: ;)
                    (NP
                      (NP
                        (NP (NNP TGFβ1) (CD -LSB-66) (-RRB- -RSB-) (: :) (CD TGFβ1))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 5) ('' '))
                          (-RRB- -RRB-)))
                      (NP (CD 5) (`` ') (NN GCG) (NN GAC) (NN TAC) (NN TAT) (NN GCT) (NN AAA) (NN GAG) (NN G3) ('' '))))))))
          (: ;)
          (NP
            (NP
              (NP (CD TGFβ1))
              (PRN (-LRB- -LRB-)
                (NP (CD 3) ('' '))
                (-RRB- -RRB-)))
            (NP (CD 5) (`` ') (NN GTT) (NN GTG) (NN TTG) (NN GTT) (NN GTA) (NN GAG) (NN GGC) (NN A3) ('' ')))
          (: ;)
          (NP (NN β-actin) (CD -LSB-67) (-RRB- -RSB-))
          (: :)
          (NP
            (NP (NN β-actin))
            (PRN (-LRB- -LRB-)
              (NP (CD 5) ('' '))
              (-RRB- -RRB-))
            (NP (CD 5) (`` ') (NN GGG) (NN TCA) (NN GAA) (NN GGA) (NN CTC) (NN CTA) (NN TG3) ('' ')))
          (: ;)
          (NP
            (NP
              (NP (NN β-actin))
              (PRN (-LRB- -LRB-)
                (NP (CD 3) ('' '))
                (-RRB- -RRB-)))
            (NP (CD 5) (`` ') (NN GTA) (NN ACA) (NN ATG) (NN CCA) (NN TGT) (NN TCA) (NN AT3) ('' '))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Thymic) (NNS lobes))
      (VP (VBD were)
        (VP (VBD dissected)
          (PP (IN from)
            (NP (NN E15.5) (NNS embryos))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (CD two) (NNS lobes))
        (PP (IN from)
          (NP (DT each) (NN embryo))))
      (VP (VBN cultured)
        (ADVP (RB separately))
        (PP (IN in)
          (NP (JJ high) (NN oxygen) (NN submersion) (NN culture)))
        (PP (IN as)
          (NP
            (ADJP (RB previously) (VBN described))
            (NN -LSB-41))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (JJ Fetal) (JJ thymic) (NN organ) (NNS cultures))
      (VP (VBD were)
        (VP (VBN supplemented)
          (PP (IN with)
            (NP
              (NP
                (NP (CD 100) (NN u/ml))
                (PP (IN of)
                  (NP (NN IL-7))))
              (CC or)
              (NP
                (NP (CD 20) (NN ng/ml))
                (PP (IN of)
                  (NP (NN SCF))))))
          (PRN (-LRB- -LRB-)
            (NP (NNP Pepro) (NNP Tech) (NNP Inc.))
            (-RRB- -RRB-))
          (PP (IN as)
            (NP
              (ADJP (RB previously) (VBN described))
              (NN -LSB-41) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (DT each) (NN embryo)))
      (, ,)
      (NP (CD one) (NN lobe))
      (VP (VBD was)
        (VP (VBN treated)
          (SBAR (IN while)
            (S
              (NP (DT the) (JJ other))
              (VP (VBD was)
                (VP (VBN cultured)
                  (PP (IN in)
                    (NP (NN parallel)))
                  (PP (IN without)
                    (NP (JJ supplemental) (NN cytokine)))
                  (PP (IN as)
                    (NP (DT an) (JJ internal) (NN control))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN control) (NNS experiments)))
      (, ,)
      (NP (NNS lobes))
      (VP (VBD were)
        (VP (VBN cultured)
          (ADVP (RB separately))
          (PP (IN under)
            (NP
              (NP (JJ identical) (NNS conditions))
              (PP (IN without)
                (NP (NN cytokine))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (CD five) (NNS days))
          (PP (IN in)
            (NP (NN culture)))))
      (, ,)
      (NP (DT the) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN stained)
            (PP (IN by)
              (NP
                (NP (JJ PE-anti-mouse) (NN CD4))
                (CC and)
                (NP (JJ FITC-anti-mouse) (NN CD8)))))
          (CC and)
          (VP (VBN analyzed)
            (PP (IN by)
              (NP
                (NP (NN flow) (NN cytometry))
                (ADVP (RB as) (RB above))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (NP (NN DMS))
      (VP
        (VP (VBD conceived)
          (PP (IN of)
            (NP (DT the) (NN study))))
        (CC and)
        (VP (VBD performed)
          (NP
            (NP (DT all))
            (PP (IN of)
              (NP
                (NP (DT the) (NNS experiments))
                (VP (VBN described))))))))
    (. .)))

(
  (S
    (S
      (NP (NN NRM))
      (VP
        (VP (VBD contributed)
          (PP (TO to)
            (NP
              (NP
                (NP (DT the) (NN design))
                (PP (IN of)
                  (NP (DT the) (NN study))))
              (CC and)
              (NP (NN data) (NN analysis)))))
        (, ,)
        (CC and)
        (VP (VBN drafted)
          (NP (DT the) (NN manuscript)))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS authors))
      (VP
        (VP (VBN read))
        (CC and)
        (VP (JJ approved)
          (NP (DT the) (JJ final) (NN manuscript)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (S
        (NP
          (NP (NN DNA) (NN synthesis) (NNS patterns))
          (PP (IN of)
            (NP
              (ADJP
                (ADJP (JJ fetal))
                (CC vs.)
                (ADJP (JJ adult)))
              (NN thymocyte) (NNS subsets)))
          (SBAR (IN as)
            (S
              (VP (VBN measured)
                (PP (IN by)
                  (NP
                    (NP (NN incorporation))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN BrdU))
                          (NP (NNP A.)))
                        (NNS Thymocytes)))))))))
        (VP (VBD were)
          (VP (VBN gated)
            (PP (IN as)
              (NP (CC either)
                (NP (JJ CD3-4-8-) (NN TN))
                (CC or)
                (NP (JJ CD3+4+8+) (NN DP))))
            (PP (IN by)
              (NP
                (NP (NN cell) (NN surface) (NN marker) (NN expression))
                (CC and)
                (NP
                  (NP (JJ forward) (NN scatter))
                  (PRN (-LRB- -LRB-)
                    (S
                      (NP (NN SP) (NNS cells))
                      (VP
                        (VP (MD should)
                          (VP (VB be)
                            (ADJP (JJ located)
                              (PP (IN between)
                                (NP (DT these) (CD two) (NNS gates))))))
                        (, ,)
                        (CC and)
                        (ADVP (RB therefore))
                        (VP (VBN excluded)
                          (PP (IN from)
                            (NP (NN analysis))))))
                    (-RRB- -RRB-))))))))
      (. .))))

(
  (S
    (S
      (NP (NNP B.) (NN Gate))
      (VP (VBN used)
        (PP (IN for)
          (NP
            (NP (NN analysis))
            (PP (IN of)
              (NP
                (NP (NN BrdU) (NN incorporation))
                (PP (IN on)
                  (NP (JJ gated) (NNS subpopulations)))))))))
    (. .)))

(
  (S
    (NP (NNS Panels)
      (NP (CD C-E)))
    (VP (VBP show)
      (NP
        (NP
          (NP
            (NP (NN CD44))
            (CC vs.)
            (NP (NN CD25)))
          (NN dot) (NNS plots))
        (PP (IN of)
          (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population)))
        (PP (IN from)
          (NP
            (NP
              (NP
                (ADJP (CD 5–6) (NN week) (JJ old))
                (JJ adult) (NN C57BL/6))
              (PRN (-LRB- -LRB-)
                (NP (NN C))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN E17.5) (JJ fetal) (NN C57BL/6))
              (PRN (-LRB- -LRB-)
                (NP (NN D))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN E17.5) (JJ fetal) (JJ RAG-/-))
              (PRN (-LRB- -LRB-)
                (NP (NN E))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Percentages))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN in)
            (NP (DT each) (NN quadrant))))))
    (. .)))

(
  (S
    (NP
      (NP (NNP F.) (NNS Percentages))
      (PP (IN of)
        (NP
          (NP (NN BrdU+) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NN Mean) (NN ±) (NN SEM))
            (-RRB- -RRB-))))
      (PP
        (PP (IN in)
          (NP
            (NP (DT each) (NN subset))
            (PP (IN of)
              (NP
                (NP (NN TN) (NNS cells))
                (VP (VBN defined)
                  (PP (IN by)
                    (NP
                      (NP (NN CD44))
                      (CC and)
                      (NP (NN CD25)))))))))
        (, ,)
        (CC and)
        (PP (IN in)
          (NP (NN DP) (NNS cells))))
      (. .))))

(
  (S
    (S
      (NP (FW G.) (JJ Adult) (JJ wild-type) (NNS thymocytes))
      (VP (VBD were)
        (VP (VBN gated)
          (PP (IN as)
            (NP (NN CD3-4-8-B220-NK1.1-))))))
    (. .)))

(
  (S
    (NP
      (NP (NNP H.) (NN CD44)
        (CC vs.)
        (NN CD25) (NN dot) (NNS plots))
      (PP (IN of)
        (NP (DT the) (JJ gated) (NN population)))
      (PP (IN from)
        (NP (-LRB- -LRB-) (NN G) (-RRB- -RRB-)))
      (. .))))

(
  (S
    (NP
      (NP (NN I.) (NN Percentage))
      (PP (IN of)
        (NP
          (NP (NN BrdU+) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NN mean) (CD ±) (NN SEM))
            (-RRB- -RRB-))))
      (PP (IN in)
        (NP
          (ADJP
            (ADJP (JJ adult))
            (CC and)
            (ADJP (JJ fetal)))
          (NN TN1) (NNS thymocytes))))
    (VP (VBG excluding)
      (NP
        (NP
          (NP
            (NP (NN B))
            (CC and)
            (NP (NN NK)))
          (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN H))
            (, ,)
            (NP (NN G)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 2))
      (: :)
      (S
        (NP
          (NP (NN Proliferation))
          (PP (IN of)
            (NP (NN E17.5) (NN Hoxa3-Pax1) (NN compound) (JJ mutant) (NNS thymocytes))))
        (VP (VBN compared)
          (PP (TO to)
            (NP (JJ wild) (NN type))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Panels))
        (ADJP (JJ A-B)))
      (VP (VBP show)
        (NP
          (NP
            (NP
              (NP (NN CD44))
              (CC vs.)
              (NP (NN CD25)))
            (NN dot) (NNS plots))
          (PP (IN of)
            (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population)))
          (PP (IN from)
            (NP (NN E17.5) (JJ wild) (NN type) (-LRB- -LRB-) (NN A) (-RRB- -RRB-)
              (CC and)
              (JJ Hoxa3+/-Pax1-/-) (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (NN thymus))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Percentages))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN in)
            (NP (DT each) (NN quadrant))))))
    (. .)))

(
  (S
    (NP
      (NP (NN C.) (NNS Percentages))
      (PP (IN of)
        (NP
          (NP (NN BrdU+) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NN Mean) (NN ±) (NN SEM))
            (-RRB- -RRB-))))
      (PP (IN in)
        (NP
          (NP (DT each))
          (PP (IN of)
            (NP
              (NP (CD 4) (NNS subsets))
              (PP (IN of)
                (NP (NN TN) (NNS cells)))
              (VP (VBN defined)
                (PP
                  (PP (IN by)
                    (NP
                      (NP (NN CD44))
                      (CC and)
                      (NP (NN CD25))))
                  (, ,)
                  (CC and)
                  (PP (IN in)
                    (NP (NN DP) (NNS cells)))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (NN D))
            (, ,)
            (NP (FW E.) (NN CD44))
            (CC vs.)
            (NP (NN CD25)))
          (NN dot) (NNS plots))
        (PP (IN of)
          (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population))))
      (VP (VBN divided)
        (PP (IN into)
          (NP (CD five) (NNS subsets)))
        (SBAR (IN as)
          (S
            (VP (VBN defined)
              (PP (IN by)
                (NP (NN -LSB-12)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NNP F.))
          (NNS Percentages))
        (PP (IN of)
          (NP
            (NP (NN BrdU+) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NN Mean) (NN ±) (NN SEM))
              (-RRB- -RRB-))))
        (PP (IN in)
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP
                (NP (CD 3) (JJ CD44-) (NN TN) (NNS subsets))
                (VP (VBN defined)
                  (PP (IN in)
                    (NP
                      (NP (NNS panels)
                        (NP
                          (NP (NN D))
                          (CC and)
                          (NP (FW E.) (NN DP) (NNS values))))
                      (VP (VBN shown)
                        (PP (IN for)
                          (NP (NN comparison))))))))))))
      (VP (VBP are)
        (NP
          (NP (DT the) (JJ same))
          (PP (IN as)
            (PP (IN in)
              (NP (NN C)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (S
        (NP
          (NP (NN Expression))
          (PP (IN of)
            (NP (NNS cytokines)))
          (PP (IN in)
            (NP
              (NP (JJ fetal) (NNS thymi))
              (PP (IN of)
                (NP
                  (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice))
                  (CC and)
                  (NP (NNS controls))))
              (VP (VBN measured)
                (PP (IN by)
                  (NP (JJ semi-quantitative) (NN RT-PCR)
                    (NP (DT Each) (NNP lane))))))))
        (VP (VBZ contains)
          (NP
            (NP (JJ pooled) (NN cDNA))
            (PP (IN from)
              (NP
                (NP (NN 5–10) (NN E14.5) (JJ embryonic) (NN thymi))
                (PP (IN of)
                  (NP (DT the) (JJ same) (NN genotype))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (JJ Representative) (NNS results))
        (PP (IN from)
          (NP
            (QP (CD one) (IN of) (CD three))
            (NNS experiments)))
        (PP (IN for)
          (NP (DT each) (NN cytokine))))
      (VP (VBP are)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP (NN β-actin))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN as)
            (NP (DT a) (NN control))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Panel) (NN A))
      (, ,)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP (NN IL-7))))
      (: ;)
      (NP (NN Panel) (NN B))
      (, ,)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP (NN SCF))))
      (. .))))

(
  (S
    (NP
      (NP (NN Table) (CD 1))
      (: :)
      (NP
        (NP
          (NP (NN Percentage))
          (PRN (-LRB- -LRB-)
            (NP (NN Mean) (NN ±) (NN SD))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP (NN BrdU+) (NNS cells)))
        (PP (IN in)
          (NP
            (NP (DT each) (NN subset))
            (PP (IN of)
              (NP (JJ fetal) (NNS thymocytes)))))))))

(
  (S
    (NP
      (NP (NN Table) (CD 2))
      (: :)
      (NP
        (NP
          (NP (NNS Percentages))
          (PRN (-LRB- -LRB-)
            (NP (NN Mean) (NN ±) (NN SD))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP (NN BrdU+) (NNS cells)))
        (PP (IN in)
          (NP
            (NP (VBN selected) (NNS subsets))
            (PP (IN of)
              (NP
                (ADJP
                  (ADJP (JJ wild-type))
                  (CC and)
                  (ADJP (JJ compound)))
                (JJ mutant) (JJ fetal) (NNS thymocytes)))))))))

